Stock | Market Cap |
Dividend Yield | P/E Ratio | Dividend Frequency |
Years Paying |
DGR |
000403.SZ PACIFIC SHUANGLIN
|
2.2 billion |
0.92% |
19.19
|
- |
3 |
-
|
000990.SZ CHENGZHI CO. LTD.
|
1.2 billion |
0.00% |
33.50
|
- |
2 |
-
|
002007.SZ HUALAN BIOLOGICA.E
|
4.3 billion |
1.74% |
22.03
|
- |
16 |
2%
|
002030.SZ DAAN GENE CO LTD
|
1.0 billion |
0.00% |
-10.17
|
- |
20 |
25%
|
002252.SZ S/H RAAS BLOOD PRO
|
6.9 billion |
0.00% |
26.89
|
- |
5 |
30%
|
002286.SZ BAOLINGBAO BIOLOGY
|
366.6 million |
1.29% |
23.73
|
1 |
13 |
28%
|
002287.SZ TIBET CHEEZHENG TI
|
1.6 billion |
2.26% |
18.94
|
- |
16 |
-
|
002566.SZ JILIN JIAN YISHENG
|
301.4 million |
0.02% |
29.73
|
1 |
5 |
-
|
002653.SZ HAISCO PHARMACEUTI
|
5.0 billion |
0.01% |
73.98
|
1 |
2 |
-
|
002873.SZ GUIYANG XINTIAN PH
|
295.3 million |
0.76% |
39.87
|
- |
7 |
26%
|
002880.SZ Shenzhen Weiguang Biological Products Co., Ltd.
|
923.4 million |
0.75% |
26.58
|
1 |
7 |
-
|
003020.SZ HEFEI LIFEON PHARM
|
467.4 million |
0.02% |
19.64
|
- |
5 |
-
|
005250.KS Green Cross Holdings Corporation
|
533.8 million |
- |
-
|
- |
19 |
-4%
|
048530.KQ iNtRON Biotechnology, Inc.
|
100.2 million |
- |
-
|
- |
2 |
-
|
064550.KQ Bioneer Corporation
|
303.2 million |
0.00% |
-
|
- |
- |
-
|
068270.KS Celltrion, Inc.
|
25.2 billion |
0.46% |
38.06
|
1 |
4 |
-
|
0690.HK Uni-Bio Science Group Limited
|
67.7 million |
4.00% |
8.50
|
- |
1 |
-
|
083790.KQ CrystalGenomics, Inc.
|
113.6 million |
0.00% |
-
|
- |
- |
-
|
084990.KQ Helixmith Co., Ltd
|
111.5 million |
0.00% |
-
|
- |
- |
-
|
087010.KQ Peptron, Inc.
|
2.7 billion |
0.00% |
-
|
- |
- |
-
|
095700.KQ Genexine, Inc.
|
165.8 million |
0.00% |
-
|
- |
- |
-
|
096530.KQ Seegene, Inc.
|
1.1 billion |
2.94% |
-
|
3 |
7 |
-30%
|
1177.HK Sino Biopharmaceutical Limited
|
10.3 billion |
1.85% |
41.18
|
4 |
22 |
10%
|
1295.TWO Synbio Tech Inc.
|
88.8 million |
0.00% |
16.18
|
- |
2 |
-
|
1530.HK 3SBio Inc.
|
5.9 billion |
0.04% |
21.41
|
- |
4 |
-
|
1733.TW APEX BIOTECHNOLOGY CORP
|
101.1 million |
0.03% |
28.70
|
1 |
22 |
-
|
1734.TW Sinphar Pharmaceutical Co.,Ltd.
|
203.3 million |
0.03% |
19.59
|
- |
23 |
30%
|
1760.TW Panion & Bf Biotech Inc.
|
233.7 million |
2.15% |
63.31
|
- |
11 |
-
|
1762.TW CHUNGHWA CHEMICAL SYNTHESIS BIO
|
87.8 million |
0.00% |
26.51
|
- |
15 |
-8%
|
177A.T Kohjin Bio Co., Ltd.
|
61.7 million |
0.80% |
18.80
|
- |
- |
-
|
206A.T PRISM BioLab Co.,LTD
|
63.7 million |
- |
-7.14
|
- |
- |
-
|
216080.KQ JETEMA, Co., Ltd.
|
182.2 million |
0.00% |
-
|
- |
- |
-
|
2183.T Linical Co., Ltd.
|
51.4 million |
0.00% |
-61.08
|
1 |
17 |
16%
|
226950.KQ OliX Pharmaceuticals,Inc
|
721.1 million |
0.00% |
-
|
- |
- |
-
|
2342.T Trans Genic Inc.
|
18.3 million |
1.60% |
-11.62
|
- |
4 |
-
|
235980.KQ MedPacto, Inc.
|
92.2 million |
0.00% |
-
|
- |
- |
-
|
2385.T Soiken Holdings Inc.
|
30.3 million |
0.03% |
-11.01
|
- |
9 |
5%
|
299660.KQ Cellid, Co., Ltd.
|
170.9 million |
0.00% |
-
|
- |
- |
-
|
300009.SZ ANHUI ANKE BIOTECH
|
1.9 billion |
0.03% |
17.79
|
- |
16 |
14%
|
300122.SZ CHONGQING ZHIFEI B
|
8.8 billion |
0.03% |
16.08
|
- |
14 |
20%
|
300181.SZ ZHEJIANG JOLLY PHA
|
1.4 billion |
0.03% |
20.27
|
1 |
13 |
30%
|
300294.SZ CHINA RESOURCES BO
|
2.1 billion |
1.38% |
80.08
|
- |
13 |
30%
|
300381.SZ GUANGDONG VTR BIO-
|
440.6 million |
0.01% |
164.75
|
- |
11 |
-
|
300583.SZ SHANDONG SITO BIO
|
509.8 million |
0.04% |
-113.53
|
- |
3 |
-
|
300653.SZ YANTAI ZHENGHAI BI
|
499.4 million |
0.04% |
21.51
|
- |
7 |
30%
|
300841.SZ Chengdu Kanghua Biological Products Co., Ltd.
|
924.6 million |
- |
12.57
|
1 |
4 |
-
|
300871.SZ HVSEN BIOTECHNOLOG
|
217.1 million |
0.02% |
-33.75
|
- |
4 |
-
|
300878.SZ ZHEJIANG WECOME PH
|
285.4 million |
0.01% |
-62.74
|
- |
1 |
-
|
300942.SZ Shenzhen Bioeasy Biotechnology Co., Ltd.
|
534.8 million |
0.18% |
191.40
|
- |
1 |
-
|
300966.SZ HUBEI GOTO BIOPHAR
|
245.0 million |
0.00% |
-127.17
|
- |
1 |
-
|
301207.SZ HUALAN BIOLOGICAL
|
1.4 billion |
0.03% |
20.51
|
- |
3 |
-
|
3118.TWO Level Biotechnology Inc.
|
37.3 million |
0.00% |
16.87
|
- |
17 |
0%
|
3164.TW GENMONT BIOTECH INC
|
58.8 million |
0.00% |
32.87
|
- |
6 |
11%
|
3759.HK PHARMARON
|
5.6 billion |
0.02% |
11.50
|
- |
5 |
-
|
4130.TWO Genovate Biotechnology Co., Ltd.
|
80.9 million |
0.01% |
125.88
|
- |
12 |
-9%
|
4133.TW ABNOVA (TAIWAN) CORPORATION
|
61.7 million |
0.02% |
30.98
|
- |
15 |
-
|
4162.TWO PharmaEngine, Inc.
|
432.5 million |
1.71% |
7.21
|
- |
10 |
30%
|
4167.TWO Savior Lifetec Corporation
|
230.3 million |
0.00% |
13.72
|
- |
2 |
-
|
4169.TWO TCM Biotech International Corp.
|
113.9 million |
0.01% |
158.06
|
1 |
2 |
-
|
4732.TWO NBM
|
42.2 million |
0.00% |
93.52
|
1 |
4 |
-
|
4880.T CellSource Co., Ltd.
|
95.3 million |
0.00% |
57.99
|
- |
3 |
-
|
4911.TWO G&E Herbal Biotechnology Co., Ltd.
|
108.6 million |
0.01% |
26.88
|
1 |
1 |
-
|
4974.T Takara Bio Inc.
|
652.1 million |
1.65% |
90.17
|
1 |
14 |
30%
|
600161.SS BEIJING TIANTAN BIOLOGICAL PROD
|
5.5 billion |
0.00% |
31.08
|
- |
- |
-
|
600201.SS JINYU BIO-TECHNOLOGY CO LTD
|
999.4 million |
0.01% |
43.53
|
- |
13 |
-3%
|
600866.SS STAR LAKE BIOSCIENCE CO INC Z
|
1.4 billion |
0.06% |
11.83
|
- |
- |
-
|
603233.SS DASHENLIN PHARMACEUTICAL GROUP
|
2.3 billion |
4.26% |
19.17
|
- |
7 |
4%
|
603392.SS BEIJING WANTAI BIOLOGICAL PHARM
|
12.4 billion |
0.00% |
-307.30
|
- |
4 |
-
|
603439.SS GUIZHOU SANLI PHARMACEUTICAL CO
|
708.6 million |
0.01% |
15.84
|
- |
2 |
-
|
603566.SS PULIKE BIOLOGICAL
|
579.8 million |
0.05% |
41.79
|
- |
- |
-
|
603590.SS Beijing Konruns Pharmaceutical Co.,Ltd.
|
699.0 million |
1.83% |
114.14
|
- |
7 |
-
|
603718.SS SHANGHAI HILE BIO-
|
579.3 million |
0.00% |
646
|
- |
2 |
-
|
603739.SS QINGDAO VLAND BIOTECH CO LTD
|
409.1 million |
0.01% |
44.65
|
- |
6 |
-30%
|
603896.SS ZHEJIANG SHOUXIANGU PHARMACEUTI
|
555.1 million |
0.01% |
16.90
|
- |
7 |
-
|
605116.SS AURISCO PHARMACEUTICAL CO LTD
|
1.1 billion |
0.01% |
24.76
|
- |
4 |
-
|
6712.TWO Ever Supreme Bio Technology Co., Ltd
|
414.0 million |
2.99% |
29.35
|
- |
4 |
-
|
6808.TWO 3D Global Biotech Inc.
|
160.1 million |
0.86% |
47.31
|
- |
- |
-
|
6821.HK Asymchem Laboratories (Tianjin) Co., Ltd.
|
4.4 billion |
0.03% |
23.81
|
1 |
4 |
-
|
6826.HK Shanghai Haohai Biological Technology Co., Ltd.
|
1.5 billion |
0.02% |
13.60
|
- |
10 |
30%
|
6846.TWO Greenyn Biotechnology Co., Ltd
|
66.3 million |
0.00% |
13.28
|
- |
3 |
-
|
6848.TWO RBC
|
8.4 million |
0.02% |
14.51
|
2 |
3 |
-
|
688075.SS ASSURE TECH (HANGZHOU) CO LTD
|
623.2 million |
0.01% |
49.61
|
- |
3 |
-
|
688076.SS SINOPEP-ALLSINO BIO PHARMACEUTI
|
1.5 billion |
0.01% |
26.32
|
- |
3 |
-
|
688098.SS SHANGHAI SHEN LIAN BIOMEDICAL C
|
294.5 million |
0.01% |
-128.75
|
- |
5 |
-26%
|
688105.SS NANJING VAZYME BIOTECH CO LTD
|
1.2 billion |
0.01% |
359.17
|
- |
3 |
-
|
688136.SS Shandong Kexing Bioproducts Co,.Ltd
|
1.5 billion |
- |
-
|
- |
- |
-
|
688278.SS XIAMEN AMOYTOP BIOTECH CO LTD
|
4.2 billion |
0.01% |
40.39
|
1 |
- |
-
|
688315.SS Novogene Co., Ltd.
|
789.1 million |
0.35% |
28.55
|
- |
4 |
-
|
688366.SS SHANGHAI HAOHAI BIOLOGICAL TECH
|
1.7 billion |
0.01% |
31.77
|
- |
5 |
30%
|
688513.SS Chengdu Easton Biopharmaceuticals Co., Ltd.
|
1.1 billion |
0.98% |
34.61
|
- |
- |
-
|
688526.SS WUHAN KEQIAN BIOLOGY CO LTD
|
870.9 million |
0.02% |
21.05
|
1 |
4 |
-
|
688578.SS SHANGHAI ALLIST PHARMACEUTICALS
|
3.7 billion |
0.01% |
20.46
|
- |
1 |
-
|
688639.SS ANHUI HUAHENG BIOTECHNOLOGY CO
|
1.0 billion |
0.01% |
22.68
|
- |
4 |
-
|
688687.SS BEIJING KAWIN TECHNOLOGY SHARE-
|
496.6 million |
0.01% |
26.63
|
1 |
4 |
-
|
688767.SS HANGZHOU BIOTEST BIOTECH CO LTD
|
471.5 million |
0.03% |
32.73
|
- |
4 |
-
|
7096.T StemCell Institute Inc.
|
74.9 million |
0.00% |
25.65
|
- |
1 |
-
|
7725.TWO LabTurbo Biotech Corporation
|
34.8 million |
0.00% |
79.26
|
- |
2 |
-
|
8279.TWO Syngen Biotech Co.,Ltd.
|
129.1 million |
3.57% |
15.80
|
- |
10 |
30%
|
AADI Aadi Bioscience, Inc.
|
94.9 million |
0.00% |
-
|
- |
- |
-
|
AARD Aardvark Therapeutics, Inc. Common Stock
|
253.0 million |
0.00% |
-9.11
|
- |
- |
-
|
ABCL AbCellera Biologics Inc.
|
721.9 million |
0.00% |
-4.32
|
- |
- |
-
|
ABCM Abcam plc
|
5.5 billion |
0.75% |
2397
|
- |
- |
-
|
ABEO Abeona Therapeutics Inc.
|
326.6 million |
0.00% |
-10.13
|
- |
- |
-
|
ABIO ARCA biopharma, Inc.
|
40.8 million |
0.00% |
-4.32
|
- |
1 |
-
|
ABSI Absci Corporation
|
354.6 million |
0.00% |
-2.99
|
- |
- |
-
|
ABUS Arbutus Biopharma Corporation
|
643.5 million |
0.00% |
-8.20
|
- |
- |
-
|
ABVC ABVC BioPharma, Inc.
|
26.8 million |
0.00% |
-8.32
|
- |
- |
-
|
ACAD ACADIA Pharmaceuticals Inc.
|
3.6 billion |
0.00% |
15.89
|
- |
- |
-
|
ACER Acer Therapeutics Inc.
|
16.1 million |
3.50% |
-1.35
|
- |
- |
-
|
ACET Adicet Bio, Inc.
|
64.4 million |
0.00% |
-0.60
|
2 |
- |
-
|
ACHL Achilles Therapeutics plc
|
56.3 million |
0.00% |
-0.83
|
- |
- |
-
|
ACHV Achieve Life Sciences, Inc.
|
146.5 million |
0.00% |
-3.13
|
- |
- |
-
|
ACIU AC Immune SA
|
160.8 million |
0.00% |
-2.62
|
- |
- |
-
|
ACST Acasti Pharma, Inc.
|
33.2 million |
0.00% |
-0.41
|
- |
- |
-
|
ACXP Acurx Pharmaceuticals, Inc.
|
8.3 million |
0.00% |
-0.51
|
- |
- |
-
|
ADAG Adagene Inc.
|
78.0 million |
0.00% |
-2.80
|
- |
- |
-
|
ADAP Adaptimmune Therapeutics plc
|
73.0 million |
0.00% |
-0.94
|
- |
- |
-
|
ADCT ADC Therapeutics SA
|
356.1 million |
0.00% |
-2.53
|
- |
- |
-
|
ADGI Adagio Therapeutics, Inc.
|
505.0 million |
- |
-
|
- |
- |
-
|
ADIL Adial Pharmaceuticals, Inc.
|
5.2 million |
0.00% |
-0.77
|
- |
- |
-
|
ADMA ADMA Biologics, Inc.
|
4.9 billion |
0.00% |
24.20
|
- |
- |
-
|
ADPT Adaptive Biotechnologies Corporation
|
1.5 billion |
0.00% |
-10.56
|
- |
- |
-
|
ADTX Aditxt, Inc.
|
3.3 million |
0.00% |
-0.06
|
- |
- |
-
|
ADVM Adverum Biotechnologies, Inc.
|
52.4 million |
0.00% |
-0.35
|
- |
- |
-
|
ADXN Addex Therapeutics Ltd
|
6.6 million |
0.00% |
-1.11
|
- |
- |
-
|
ADXS Advaxis, Inc.
|
1.5 million |
0.00% |
-0.34
|
- |
- |
-
|
AEON
|
- |
- |
-
|
- |
- |
-
|
AEZS Aeterna Zentaris Inc.
|
18.1 million |
0.00% |
-0.37
|
- |
- |
-
|
AFMD Affimed N.V.
|
3.0 million |
0.00% |
-
|
- |
- |
-
|
AGE AgeX Therapeutics, Inc.
|
33.2 million |
0.00% |
-1.02
|
- |
- |
-
|
AGEN Agenus Inc.
|
137.1 million |
0.00% |
0.17
|
- |
- |
-
|
AGIO Agios Pharmaceuticals, Inc.
|
1.9 billion |
0.00% |
2.83
|
- |
- |
-
|
AGLE Spyre Therapeutics, Inc.
|
48.6 million |
- |
-4.70
|
- |
- |
-
|
AGTC Applied Genetic Technologies Corporation
|
26.6 million |
- |
-2.28
|
- |
- |
-
|
AIKI AIkido Pharma Inc.
|
19.4 million |
- |
-0.24
|
- |
- |
-
|
AIM AIM ImmunoTech Inc.
|
6.5 million |
0.00% |
-
|
- |
- |
-
|
AKRO Akero Therapeutics, Inc.
|
4.2 billion |
0.00% |
-14.13
|
- |
- |
-
|
AKTX Akari Therapeutics, Plc
|
21560 |
0.00% |
-0.52
|
- |
- |
-
|
AKUS Akouos, Inc.
|
491.0 million |
- |
-
|
- |
- |
-
|
ALBO Albireo Pharma, Inc.
|
920.7 million |
- |
-11.67
|
- |
- |
-
|
ALDX Aldeyra Therapeutics, Inc.
|
140.9 million |
0.00% |
-2.43
|
- |
- |
-
|
ALEC Alector, Inc.
|
145.5 million |
0.00% |
-1.15
|
- |
- |
-
|
ALGS Aligos Therapeutics, Inc.
|
36.4 million |
0.00% |
-0.34
|
- |
- |
-
|
ALK-B.CO ALK-Abelló A/S
|
6.3 billion |
0.00% |
43.63
|
- |
- |
-
|
ALLK Allakos Inc.
|
29.4 million |
0.00% |
-0.25
|
- |
- |
-
|
ALLO Allogene Therapeutics, Inc.
|
282.2 million |
0.00% |
-1.06
|
- |
- |
-
|
ALLR Allarity Therapeutics, Inc.
|
13.3 million |
0.00% |
-0.07
|
- |
- |
-
|
ALNA Allena Pharmaceuticals, Inc.
|
9.2 million |
- |
-1.19
|
- |
- |
-
|
ALNY Alnylam Pharmaceuticals, Inc.
|
39.9 billion |
0.00% |
-145.68
|
- |
- |
-
|
ALPN Alpine Immune Sciences, Inc.
|
4.5 billion |
0.00% |
-22.30
|
- |
- |
-
|
ALRN Aileron Therapeutics, Inc.
|
41.8 million |
0.00% |
-1.64
|
- |
- |
-
|
ALT Altimmune, Inc.
|
439.6 million |
0.00% |
-4.30
|
- |
- |
-
|
ALVR AlloVir, Inc.
|
50.9 million |
0.00% |
-0.50
|
- |
- |
-
|
ALXN Alexion Pharmaceuticals, Inc.
|
40.3 billion |
- |
59.23
|
- |
- |
-
|
ALXO ALX Oncology Holdings Inc.
|
28.5 million |
0.00% |
-0.22
|
- |
- |
-
|
ALZN Alzamend Neuro, Inc.
|
3.1 million |
0.00% |
-0.01
|
- |
- |
-
|
AMAM Ambrx Biopharma Inc.
|
1.8 billion |
0.00% |
66.14
|
- |
- |
-
|
AMLX Amylyx Pharmaceuticals, Inc.
|
456.4 million |
0.00% |
-1.65
|
- |
- |
-
|
AMPE Ampio Pharmaceuticals, Inc.
|
36388 |
0.00% |
-0.15
|
- |
- |
-
|
AMTI Applied Molecular Transport Inc.
|
11.0 million |
- |
-0.14
|
- |
- |
-
|
ANAB AnaptysBio, Inc.
|
578.0 million |
- |
68.66
|
- |
- |
-
|
ANEB Anebulo Pharmaceuticals, Inc.
|
44.4 million |
0.00% |
-4.32
|
- |
- |
-
|
ANGN Angion Biomedica Corp.
|
20.4 million |
- |
-
|
- |
- |
-
|
ANIX Anixa Biosciences, Inc.
|
90.8 million |
0.00% |
-7.42
|
- |
- |
-
|
ANNX Annexon, Inc.
|
266.6 million |
0.00% |
-2.08
|
- |
- |
-
|
ANPC Fresh2 Group Limited
|
27.0 million |
- |
-
|
- |
- |
-
|
ANTH Anthera Pharmaceuticals, Inc.
|
6178 |
- |
0.00
|
- |
- |
-
|
ANTX AN2 Therapeutics, Inc.
|
32.0 million |
0.00% |
-0.70
|
3 |
- |
-
|
ANVS Annovis Bio, Inc.
|
65.9 million |
0.00% |
-1.51
|
- |
- |
-
|
APLS Apellis Pharmaceuticals, Inc.
|
2.4 billion |
0.00% |
-10.46
|
- |
- |
-
|
APLT Applied Therapeutics, Inc.
|
53.1 million |
0.00% |
-1.56
|
- |
- |
-
|
APM Aptorum Group Limited
|
7.0 million |
- |
2.70
|
- |
- |
-
|
APOP Cellect Biotechnology Ltd.
|
51.5 million |
- |
-0.82
|
- |
- |
-
|
APRE Aprea Therapeutics, Inc.
|
10.0 million |
0.00% |
-0.78
|
- |
- |
-
|
APTO Aptose Biosciences, Inc.
|
4.4 million |
0.00% |
-0.05
|
- |
- |
-
|
APTX Aptinyx Inc.
|
4.4 million |
- |
-2.48
|
- |
- |
-
|
APVO Aptevo Therapeutics Inc.
|
3.5 million |
0.00% |
-0.02
|
- |
- |
-
|
ARAV Aravive, Inc.
|
2.9 million |
- |
-0.05
|
- |
- |
-
|
ARBS.MI Arterra Bioscience
|
17.6 million |
- |
10.86
|
- |
4 |
-
|
ARCT Arcturus Therapeutics Holdings Inc.
|
335.8 million |
0.00% |
-
|
1 |
- |
-
|
ARDS Aridis Pharmaceuticals, Inc.
|
4457 |
0.00% |
-
|
- |
- |
-
|
ARDX Ardelyx, Inc.
|
882.9 million |
0.00% |
-16.04
|
- |
- |
-
|
ARGX argenx SE
|
35.2 billion |
0.00% |
35.20
|
- |
- |
-
|
ARMP Armata Pharmaceuticals, Inc.
|
72.4 million |
0.00% |
-5
|
- |
- |
-
|
ARNA Arena Pharmaceuticals, Inc.
|
6.2 billion |
- |
-6.17
|
- |
- |
-
|
ARQT Arcutis Biotherapeutics, Inc.
|
1.6 billion |
0.00% |
-12.76
|
- |
- |
-
|
ARTL Artelo Biosciences, Inc.
|
3.5 million |
0.00% |
-0.36
|
- |
- |
-
|
ARTV Artiva Biotherapeutics, Inc.
|
47.5 million |
0.00% |
-0.32
|
- |
- |
-
|
ARVN Arvinas, Inc.
|
507.3 million |
0.00% |
-10.53
|
- |
- |
-
|
ARWR Arrowhead Pharmaceuticals, Inc.
|
2.3 billion |
0.00% |
-13.23
|
- |
- |
-
|
ASLN ASLAN Pharmaceuticals Limited
|
6.7 million |
0.00% |
-0.19
|
- |
- |
-
|
ASMB Assembly Biosciences, Inc.
|
116.1 million |
0.00% |
-2.45
|
- |
- |
-
|
ASND Ascendis Pharma A/S
|
10.7 billion |
0.00% |
-27.05
|
- |
- |
-
|
ATAI Atai Life Sciences N.V.
|
470.8 million |
0.00% |
-2.58
|
1 |
- |
-
|
ATHA Athira Pharma, Inc.
|
11.1 million |
0.00% |
-0.14
|
- |
- |
-
|
ATHE Alterity Therapeutics Limited
|
68.1 million |
0.00% |
-2.30
|
- |
- |
-
|
ATHX Athersys, Inc.
|
459479 |
1.02% |
0.72
|
- |
- |
-
|
ATNF 180 Life Sciences Corp.
|
6.1 million |
0.00% |
-0.07
|
- |
- |
-
|
ATNFW CannBioRx Life Sciences Corp.
|
6.6 million |
0.00% |
-
|
- |
- |
-
|
ATNM Actinium Pharmaceuticals, Inc.
|
52.4 million |
0.00% |
-1.14
|
- |
- |
-
|
ATOS Atossa Therapeutics, Inc.
|
110.1 million |
0.00% |
-4.26
|
- |
- |
-
|
ATRA Atara Biotherapeutics, Inc.
|
59.9 million |
0.00% |
-
|
- |
- |
-
|
ATXI Avenue Therapeutics, Inc.
|
637038 |
0.00% |
-0.20
|
- |
- |
-
|
ATXS Astria Therapeutics, Inc.
|
284.1 million |
0.00% |
-2.68
|
- |
- |
-
|
AUPH Aurinia Pharmaceuticals Inc.
|
1.1 billion |
0.00% |
29.59
|
- |
- |
-
|
AURA Aura Biosciences, Inc.
|
380.7 million |
0.00% |
-3.23
|
- |
- |
-
|
AUTL Autolus Therapeutics plc
|
556.2 million |
0.00% |
-2.37
|
- |
- |
-
|
AVEO AVEO Pharmaceuticals, Inc.
|
521.4 million |
- |
-3.94
|
- |
- |
-
|
AVIR Atea Pharmaceuticals, Inc.
|
276.4 million |
0.00% |
-1.96
|
- |
- |
-
|
AVRO AVROBIO, Inc.
|
68.2 million |
0.00% |
2.20
|
- |
- |
-
|
AVTX Avalo Therapeutics, Inc.
|
47.0 million |
0.00% |
0.04
|
- |
- |
-
|
AVXL Anavex Life Sciences Corp.
|
665.5 million |
0.00% |
-13.92
|
- |
- |
-
|
AXLA Axcella Health Inc.
|
1.2 million |
- |
-0.02
|
- |
- |
-
|
AXSM Axsome Therapeutics, Inc.
|
5.3 billion |
0.00% |
-18.66
|
- |
- |
-
|
AYLA Ayala Pharmaceuticals, Inc.
|
7.5 million |
- |
-
|
- |
- |
-
|
AZRX AzurRx BioPharma, Inc.
|
271.1 million |
- |
-1.26
|
- |
- |
-
|
BAVA.CO Bavarian Nordic A/S
|
2.2 billion |
0.00% |
10.85
|
- |
- |
-
|
BBI Brickell Biotech, Inc.
|
6.8 million |
- |
-0.60
|
- |
- |
-
|
BBIO BridgeBio Pharma, Inc.
|
7.3 billion |
0.00% |
-10.74
|
- |
- |
-
|
BBZA.DE BB Biotech AG
|
2.1 billion |
4.90% |
13.42
|
1 |
13 |
-10%
|
BCAB BioAtla, Inc.
|
30.4 million |
0.00% |
-0.43
|
- |
- |
-
|
BCAX Bicara Therapeutics Inc. Common Stock
|
600.4 million |
0.00% |
-6.51
|
- |
- |
-
|
BCDA BioCardia, Inc.
|
11.7 million |
0.00% |
-1.06
|
- |
- |
-
|
BCDAW BioCardia, Inc.
|
4.4 million |
0.00% |
-0.01
|
- |
- |
-
|
BCEL Atreca, Inc.
|
3.6 million |
0.00% |
-0.11
|
- |
- |
-
|
BCLI Brainstorm Cell Therapeutics Inc.
|
8.9 million |
0.00% |
-0.56
|
- |
- |
-
|
BCRX BioCryst Pharmaceuticals, Inc.
|
2.2 billion |
0.00% |
-41.27
|
- |
- |
-
|
BCTX BriaCell Therapeutics Corp.
|
18.5 million |
0.00% |
-0.71
|
- |
- |
-
|
BCTXW BriaCell Therapeutics Corp.
|
294441 |
0.00% |
-
|
- |
- |
-
|
BCTXZ BriaCell Therapeutics Corp. Warrant
|
3.8 million |
- |
-
|
- |
- |
-
|
BCYC Bicycle Therapeutics plc
|
585.5 million |
0.00% |
-2.68
|
- |
- |
-
|
BDTX Black Diamond Therapeutics, Inc.
|
144.1 million |
0.00% |
42.25
|
- |
- |
-
|
BEAM Beam Therapeutics Inc.
|
1.6 billion |
0.00% |
-3.51
|
4 |
- |
-
|
BFRA Biofrontera AG
|
80.2 million |
- |
-8.15
|
- |
- |
-
|
BGBIO.OL BerGenBio ASA
|
5.3 million |
0.00% |
-0.34
|
- |
- |
-
|
BGNE BeiGene, Ltd.
|
20.2 billion |
0.00% |
-
|
- |
- |
-
|
BHVN Biohaven Ltd.
|
1.7 billion |
0.00% |
-1.76
|
- |
- |
-
|
BIO3.DE Biotest AG
|
1.7 billion |
0.00% |
-47.62
|
1 |
2 |
-
|
BIOCON.BO Biocon Limited
|
4.6 billion |
0.15% |
39.08
|
- |
4 |
-
|
BIOCON.NS Biocon Limited
|
4.7 billion |
0.15% |
39.49
|
- |
4 |
-
|
BIO.DE Biotest AG
|
1.6 billion |
0.00% |
-67.30
|
1 |
2 |
-
|
BION.SW BB Biotech AG
|
2.1 billion |
5.16% |
13.47
|
1 |
13 |
-6%
|
BIVI BioVie Inc.
|
20.6 million |
0.00% |
-0.85
|
- |
- |
-
|
BLCM Bellicum Pharmaceuticals, Inc.
|
778326 |
0.00% |
-0.13
|
- |
- |
-
|
BLI Berkeley Lights, Inc.
|
86.6 million |
- |
-
|
- |
- |
-
|
BLPH Bellerophon Therapeutics, Inc.
|
232419 |
0.00% |
-0.07
|
- |
- |
-
|
BLRX BioLineRx Ltd.
|
15.7 million |
0.00% |
-0.70
|
- |
- |
-
|
BLU BELLUS Health Inc.
|
1.8 billion |
- |
-4.06
|
- |
- |
-
|
BLUE bluebird bio, Inc.
|
48.7 million |
0.00% |
-0.24
|
- |
- |
-
|
BLUEJET.BO Blue Jet Healthcare Limited
|
1.8 billion |
0.12% |
51.58
|
- |
1 |
-
|
BLUEJET.NS Blue Jet Healthcare Limited
|
1.8 billion |
0.12% |
51.13
|
- |
1 |
-
|
BMEA Biomea Fusion, Inc.
|
95.1 million |
0.00% |
-0.71
|
- |
- |
-
|
BMRN BioMarin Pharmaceutical Inc.
|
10.8 billion |
0.00% |
20.86
|
- |
- |
-
|
BNOX Bionomics Limited - American De
|
6.3 million |
0.00% |
-0.38
|
- |
- |
-
|
BNTC Benitec Biopharma Inc.
|
396.4 million |
0.00% |
-3.08
|
- |
- |
-
|
BNTX BioNTech SE
|
26.7 billion |
0.00% |
-30.70
|
- |
- |
-
|
BOLT Bolt Biotherapeutics, Inc.
|
12.4 million |
0.00% |
-0.20
|
4 |
- |
-
|
BOT.AX Botanix Pharmaceuticals Limited
|
411.5 million |
0.00% |
-16.10
|
- |
- |
-
|
BPMC Blueprint Medicines Corporation
|
8.3 billion |
0.00% |
-50.91
|
- |
- |
-
|
BPTH Bio-Path Holdings, Inc.
|
1.5 million |
0.00% |
0.49
|
- |
- |
-
|
BRAX.CN BraxiaScience
|
1.0 million |
0.00% |
-0.10
|
- |
- |
-
|
BRNS Barinthus Biotherapeutics plc
|
42.0 million |
- |
-0.63
|
- |
- |
-
|
BRTX BioRestorative Therapies, Inc.
|
13.5 million |
0.00% |
-1.22
|
- |
- |
-
|
BSTG Harvard Apparatus Regenerative Technology Inc.
|
81.3 million |
- |
-2.69
|
- |
- |
-
|
BTAI BioXcel Therapeutics, Inc.
|
8.3 million |
0.00% |
-0.12
|
- |
- |
-
|
BTTX Better Therapeutics, Inc.
|
5452 |
0.00% |
-
|
- |
- |
-
|
BTX Eterna Therapeutics Inc.
|
12.0 million |
- |
17.81
|
- |
- |
-
|
BVXP.L Bioventix PLC
|
2.0 million |
0.05% |
18.97
|
2 |
12 |
20%
|
BVXV BiondVax Pharmaceuticals Ltd.
|
6.3 million |
- |
-0.95
|
- |
- |
-
|
BYSI BeyondSpring Inc.
|
68.1 million |
0.00% |
-7.68
|
- |
- |
-
|
CABA Cabaletta Bio, Inc.
|
110.6 million |
0.00% |
-0.86
|
- |
- |
-
|
CADL Candel Therapeutics, Inc.
|
280.6 million |
0.00% |
-4.21
|
- |
- |
-
|
CALA Calithera Biosciences, Inc.
|
9745 |
0.00% |
-3.31
|
- |
- |
-
|
CALT Calliditas Therapeutics AB
|
1.1 billion |
0.00% |
-
|
- |
- |
-
|
CAMP CAMP4 Therapeutics Corporation
|
38.3 million |
0.00% |
-0.74
|
- |
- |
-
|
CANF Can-Fite BioPharma Ltd.
|
14.3 million |
0.00% |
-0.43
|
- |
- |
-
|
CAPR Capricor Therapeutics, Inc.
|
509.6 million |
0.00% |
-8.14
|
- |
- |
-
|
CARA Cara Therapeutics, Inc.
|
22.6 million |
0.00% |
-0.32
|
- |
- |
-
|
CARM Carisma Therapeutics, Inc.
|
7.3 million |
0.00% |
-0.14
|
- |
- |
-
|
CASI CASI Pharmaceuticals, Inc.
|
29.9 million |
0.00% |
-0.76
|
- |
- |
-
|
CATB Catabasis Pharmaceuticals, Inc.
|
657.1 million |
- |
-0.66
|
- |
- |
-
|
CBAY CymaBay Therapeutics, Inc.
|
3.7 billion |
0.00% |
-34.58
|
- |
- |
-
|
CBIO Catalyst Biosciences, Inc.
|
19.4 million |
792.92% |
1.67
|
- |
- |
-
|
CBLI Cleveland BioLabs, Inc.
|
49.0 million |
0.00% |
-16.82
|
- |
- |
-
|
CCCC C4 Therapeutics, Inc.
|
101.9 million |
0.00% |
-0.97
|
- |
- |
-
|
CCXI ChemoCentryx, Inc.
|
3.7 billion |
4.97% |
-91.33
|
- |
- |
-
|
CDAK Codiak BioSciences, Inc.
|
2.8 million |
- |
-
|
- |
- |
-
|
CDMO Avid Bioservices, Inc.
|
798.9 million |
0.00% |
-
|
- |
- |
-
|
CDMOP Avid Bioservices, Inc.
|
205.1 million |
10.10% |
-
|
3 |
- |
-
|
CDTX Cidara Therapeutics, Inc.
|
302.2 million |
0.00% |
-0.87
|
- |
- |
-
|
CDXS Codexis, Inc.
|
185.6 million |
0.00% |
-
|
- |
- |
-
|
CELC Celcuity Inc.
|
440.0 million |
0.00% |
-3.81
|
- |
- |
-
|
CELU Celularity Inc.
|
50.3 million |
0.00% |
-0.80
|
- |
- |
-
|
CELUW Celularity Inc.
|
1.1 million |
0.00% |
-0.05
|
- |
- |
-
|
CELZ Creative Medical Technology Holdings, Inc.
|
5.9 million |
0.00% |
-0.60
|
- |
- |
-
|
CERE Cerevel Therapeutics Holdings,
|
7.5 billion |
0.00% |
-17.17
|
- |
- |
-
|
CFRX ContraFect Corporation
|
267940 |
- |
-2.36
|
- |
- |
-
|
CGEM Cullinan Oncology, Inc.
|
535.3 million |
0.00% |
-3.27
|
- |
- |
-
|
CGEN Compugen Ltd.
|
171.1 million |
0.00% |
-11.44
|
- |
- |
-
|
CGTX Cognition Therapeutics, Inc.
|
18.7 million |
0.00% |
-0.42
|
- |
- |
-
|
CHRS Coherus BioSciences, Inc.
|
90.7 million |
0.00% |
1.78
|
- |
- |
-
|
CINC CinCor Pharma, Inc.
|
1.3 billion |
- |
-
|
- |
- |
-
|
CING Cingulate Inc.
|
16.6 million |
0.00% |
-0.97
|
- |
- |
-
|
CINGW Cingulate Inc.
|
197426 |
0.00% |
-0.03
|
- |
- |
-
|
CKPT Checkpoint Therapeutics, Inc.
|
367.7 million |
0.00% |
-3.33
|
- |
- |
-
|
CLBS Caladrius Biosciences, Inc.
|
25.8 million |
- |
-2.40
|
- |
- |
-
|
CLDX Celldex Therapeutics, Inc.
|
1.3 billion |
0.00% |
-7.29
|
- |
- |
-
|
CLGN CollPlant Biotechnologies Ltd.
|
25.2 million |
0.00% |
-1.82
|
- |
- |
-
|
CLLS Cellectis S.A.
|
148.9 million |
0.00% |
-2.18
|
- |
- |
-
|
CLRB Cellectar Biosciences, Inc.
|
12.8 million |
0.00% |
-0.44
|
- |
- |
-
|
CLSD Clearside Biomedical, Inc.
|
57.5 million |
0.00% |
-1.85
|
- |
- |
-
|
CLSN Imunon, Inc.
|
13.9 million |
- |
-2.12
|
- |
- |
-
|
CLVLF Clinuvel Pharmaceuticals Limited
|
348.4 million |
- |
14.18
|
1 |
7 |
30%
|
CLVLY Clinuvel Pharmaceuticals Limited
|
336.3 million |
0.70% |
13.69
|
1 |
7 |
20%
|
CLVS Clovis Oncology, Inc.
|
34.8 million |
0.92% |
-1.42
|
- |
- |
-
|
CLXT Calyxt, Inc.
|
31.3 million |
- |
-3.73
|
- |
- |
-
|
CMMB Chemomab Therapeutics Ltd.
|
1.3 million |
0.00% |
-2.11
|
- |
- |
-
|
CMPI Checkmate Pharmaceuticals, Inc.
|
227.1 million |
- |
-
|
- |
- |
-
|
CMRX Chimerix, Inc.
|
801.1 million |
0.00% |
-
|
- |
- |
-
|
CMXHF CSL Limited
|
79.9 billion |
1.34% |
30.32
|
2 |
22 |
0%
|
CNCE Concert Pharmaceuticals, Inc.
|
403.4 million |
- |
-4.28
|
- |
- |
-
|
CNSP CNS Pharmaceuticals, Inc.
|
5.8 million |
0.00% |
-0.04
|
- |
- |
-
|
CNST Constellation Pharmaceuticals, Inc.
|
1.6 billion |
- |
-7.75
|
- |
- |
-
|
CNTA Centessa Pharmaceuticals plc
|
1.8 billion |
0.00% |
-7.11
|
- |
- |
-
|
CNTB Connect Biopharma Holdings Limited
|
42.7 million |
0.00% |
-2.49
|
- |
- |
-
|
COCP Cocrystal Pharma, Inc.
|
17.1 million |
0.00% |
-1.08
|
- |
- |
-
|
COGT Cogent Biosciences, Inc.
|
638.7 million |
0.00% |
-2.85
|
- |
- |
-
|
COMBI.ST CombiGene AB (publ)
|
5.1 million |
0.00% |
-1.07
|
- |
1 |
-
|
CONCORDBIO.BO Concord Biotech Limited
|
2.2 billion |
0.00% |
52
|
- |
1 |
-
|
CONCORDBIO.NS Concord Biotech Limited
|
2.2 billion |
0.00% |
51.70
|
- |
1 |
-
|
CORT Corcept Therapeutics Incorporated
|
7.6 billion |
0.00% |
62.33
|
- |
- |
-
|
COYA Coya Therapeutics, Inc.
|
95.5 million |
0.00% |
-5.34
|
- |
- |
-
|
CPRX Catalyst Pharmaceuticals, Inc.
|
3.0 billion |
0.00% |
15.89
|
- |
- |
-
|
CRBP Corbus Pharmaceuticals Holdings, Inc.
|
89.8 million |
0.00% |
-1.73
|
- |
- |
-
|
CRBU Caribou Biosciences, Inc.
|
97.7 million |
0.00% |
-0.65
|
- |
- |
-
|
CRDF Cardiff Oncology, Inc.
|
233.5 million |
0.00% |
-3.77
|
- |
- |
-
|
CRIS Curis, Inc.
|
24.7 million |
0.00% |
-0.39
|
- |
- |
-
|
CRMD CorMedix Inc.
|
855.3 million |
0.00% |
50.44
|
- |
- |
-
|
CRNX Crinetics Pharmaceuticals, Inc.
|
3.0 billion |
0.00% |
-8.46
|
- |
- |
-
|
CRSP CRISPR Therapeutics AG
|
3.3 billion |
0.00% |
-
|
- |
- |
-
|
CRTX Cortexyme, Inc.
|
58.3 million |
- |
-20.13
|
- |
- |
-
|
CRVS Corvus Pharmaceuticals, Inc.
|
289.2 million |
0.00% |
-3.64
|
- |
- |
-
|
CSBR Champions Oncology, Inc.
|
91.4 million |
0.00% |
14.69
|
- |
- |
-
|
CSCI.TO COSCIENS BIOPHARMA INC
|
11.6 million |
0.00% |
-
|
- |
- |
-
|
CSL.AX CSL Limited
|
76.7 billion |
0.00% |
28.92
|
2 |
32 |
10%
|
CSLLY CSL Limited
|
153.9 billion |
3.09% |
29.21
|
2 |
17 |
6%
|
CTIC CTI BioPharma Corp.
|
646.2 million |
- |
-3.92
|
- |
- |
-
|
CTMX CytomX Therapeutics, Inc.
|
417.5 million |
0.00% |
5.52
|
- |
- |
-
|
CTNM Contineum Therapeutics, Inc. Class A Common Stock
|
118.2 million |
- |
-1.83
|
- |
- |
-
|
CTXR Citius Pharmaceuticals, Inc.
|
9.0 million |
0.00% |
-0.15
|
- |
- |
-
|
CUE Cue Biopharma, Inc.
|
47.2 million |
0.00% |
-0.98
|
- |
- |
-
|
CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
|
98.2 million |
- |
-76.33
|
- |
- |
-
|
CUV.AX Clinuvel Pharmaceuticals Limited
|
338.4 million |
0.00% |
13.45
|
- |
7 |
22%
|
CVAC CureVac N.V.
|
1.1 billion |
0.00% |
5.17
|
- |
- |
-
|
CVM CEL-SCI Corporation
|
12.4 million |
0.00% |
-0.20
|
- |
- |
-
|
CWBR CohBar Inc.
|
1.2 million |
0.00% |
-0.20
|
- |
- |
-
|
CYAD Celyad Oncology SA
|
16.4 million |
- |
-3.91
|
- |
- |
-
|
CYBN Cybin Inc.
|
174.9 million |
0.00% |
-2.32
|
- |
- |
-
|
CYCC Cyclacel Pharmaceuticals, Inc.
|
7.5 million |
0.00% |
0.10
|
- |
1 |
-
|
CYCCP Cyclacel Pharmaceuticals, Inc.
|
2.1 million |
6.15% |
-9.72
|
4 |
11 |
-
|
CYCN Cyclerion Therapeutics, Inc.
|
10.5 million |
0.00% |
-2.84
|
- |
- |
-
|
CYT Cyteir Therapeutics, Inc.
|
108.7 million |
0.00% |
-3.38
|
4 |
- |
-
|
CYTK Cytokinetics, Incorporated
|
3.9 billion |
0.00% |
-6.13
|
- |
- |
-
|
CYTO Altamira Therapeutics Ltd.
|
2.0 million |
0.00% |
0.28
|
- |
- |
-
|
CYTR LadRx Corporation
|
4.1 million |
- |
-2.19
|
- |
- |
-
|
CZO.V Ceapro Inc
|
16.7 million |
0.00% |
-5.83
|
- |
- |
-
|
DARE Daré Bioscience, Inc.
|
27.3 million |
0.00% |
-18.18
|
- |
- |
-
|
DAWN Day One Biopharmaceuticals, Inc.
|
707.5 million |
0.00% |
-10.74
|
- |
- |
-
|
DBTX Decibel Therapeutics, Inc.
|
84.3 million |
- |
-
|
- |
- |
-
|
DBVT DBV Technologies S.A.
|
222.6 million |
0.00% |
-1.42
|
- |
- |
-
|
DFFN Diffusion Pharmaceuticals Inc.
|
7.8 million |
- |
-2.01
|
- |
- |
-
|
DICE DICE Therapeutics, Inc.
|
1.6 billion |
- |
11.66
|
- |
- |
-
|
DMAC DiaMedica Therapeutics Inc.
|
180.1 million |
0.00% |
-6.56
|
- |
- |
-
|
DNA Ginkgo Bioworks Holdings, Inc.
|
523.3 million |
0.00% |
-
|
- |
- |
-
|
DNLI Denali Therapeutics Inc.
|
2.0 billion |
0.00% |
-5.28
|
- |
- |
-
|
DOMH Dominari Holdings Inc.
|
71.0 million |
0.00% |
-1.08
|
- |
1 |
-
|
DRMA Dermata Therapeutics, Inc.
|
4.5 million |
0.00% |
-0.49
|
- |
- |
-
|
DRMAW Dermata Therapeutics, Inc.
|
4.3 million |
0.00% |
-0.01
|
- |
- |
-
|
DRNA Dicerna Pharmaceuticals, Inc.
|
2.9 billion |
- |
-14.22
|
- |
- |
-
|
DRUG Bright Minds Biosciences Inc.
|
198.7 million |
0.00% |
-200.36
|
- |
- |
-
|
DSGN Design Therapeutics, Inc.
|
216.0 million |
0.00% |
-3.84
|
- |
- |
-
|
DTIL Precision BioSciences, Inc.
|
57.6 million |
0.00% |
-1.81
|
- |
- |
-
|
DWTX Dogwood Therapeutics, Inc.
|
10.7 million |
0.00% |
-0.29
|
- |
- |
-
|
DYAI Dyadic International, Inc.
|
30.2 million |
0.00% |
-5.02
|
- |
- |
-
|
DYN Dyne Therapeutics, Inc.
|
1.5 billion |
0.00% |
-3.71
|
4 |
- |
-
|
EARS Auris Medical Holding Ltd.
|
39.2 million |
3.88% |
-0.56
|
- |
- |
-
|
EDIT Editas Medicine, Inc.
|
149.1 million |
0.00% |
-0.58
|
- |
- |
-
|
EDSA Edesa Biotech, Inc.
|
14.0 million |
0.00% |
-1.28
|
- |
- |
-
|
EFTR eFFECTOR Therapeutics, Inc.
|
941 |
0.00% |
-0.65
|
- |
- |
-
|
EFTRW eFFECTOR Therapeutics, Inc.
|
23.4 million |
0.00% |
-0.12
|
- |
- |
-
|
EIGR Eiger BioPharmaceuticals, Inc.
|
2.6 million |
0.00% |
-0.10
|
- |
- |
-
|
ELDN Eledon Pharmaceuticals, Inc.
|
181.4 million |
0.00% |
-75.75
|
- |
- |
-
|
ELEV Elevation Oncology, Inc.
|
18.0 million |
0.00% |
-0.38
|
- |
- |
-
|
ELOX Eloxx Pharmaceuticals, Inc.
|
314 |
0.00% |
-0.10
|
- |
- |
-
|
ELVN Enliven Therapeutics, Inc.
|
1.1 billion |
0.00% |
-11.39
|
- |
- |
-
|
ELYM Eliem Therapeutics, Inc
|
342.7 million |
0.00% |
-1.85
|
- |
- |
-
|
EMMA Emmaus Life Sciences, Inc.
|
1.3 million |
0.00% |
-0.28
|
- |
- |
-
|
ENLV Enlivex Therapeutics Ltd.
|
22.2 million |
0.00% |
-1.41
|
- |
- |
-
|
ENOB Enochian Biosciences Inc.
|
72.4 million |
- |
-14.56
|
- |
- |
-
|
ENSC Ensysce Biosciences, Inc.
|
5.5 million |
0.00% |
0.02
|
- |
- |
-
|
ENTA Enanta Pharmaceuticals, Inc.
|
152.4 million |
0.00% |
-1.57
|
- |
- |
-
|
ENTX Entera Bio Ltd.
|
87.7 million |
0.00% |
-7.42
|
- |
- |
-
|
ENVB Enveric Biosciences, Inc.
|
3.1 million |
0.00% |
-0.11
|
- |
- |
-
|
ENZN Enzon Pharmaceuticals, Inc.
|
6.4 million |
0.00% |
-4.30
|
1 |
- |
-
|
EPIX ESSA Pharma Inc.
|
75.9 million |
0.00% |
-2.67
|
- |
- |
-
|
EPZM Epizyme, Inc.
|
247.5 million |
1.66% |
-5.27
|
- |
- |
-
|
EQ Equillium, Inc.
|
13.1 million |
0.00% |
-0.94
|
- |
- |
-
|
EQRX EQRx, Inc.
|
1.2 billion |
- |
-
|
- |
- |
-
|
EQRXW EQRx, Inc.
|
- |
- |
-
|
- |
- |
-
|
ERAS Erasca, Inc.
|
433.4 million |
0.00% |
-2.68
|
- |
- |
-
|
ERYP PHAXIAM Therapeutics S.A.
|
23.9 million |
- |
-1.86
|
- |
- |
-
|
ETNB 89bio, Inc.
|
1.5 billion |
0.00% |
-2.94
|
- |
- |
-
|
ETTX Entasis Therapeutics Holdings Inc.
|
104.3 million |
- |
-0.51
|
- |
- |
-
|
EVAX Evaxion Biotech A/S
|
3.8 million |
0.00% |
-0.23
|
- |
- |
-
|
EVFM Evofem Biosciences, Inc.
|
1.1 million |
0.00% |
0.25
|
- |
- |
-
|
EVFMD Evofem Biosciences, Inc.
|
- |
- |
-
|
- |
- |
-
|
EVGN Evogene Ltd.
|
7.4 million |
0.00% |
-0.44
|
- |
- |
-
|
EVLO Evelo Biosciences, Inc.
|
37966 |
0.00% |
-1.81
|
- |
- |
-
|
EWTX Edgewise Therapeutics, Inc.
|
1.5 billion |
0.00% |
-9.48
|
- |
- |
-
|
EXAI Exscientia Plc
|
733.9 million |
0.00% |
-
|
- |
- |
-
|
EXEL Exelixis, Inc.
|
11.6 billion |
0.00% |
19.45
|
- |
- |
-
|
EYEG EyeGate Pharmaceuticals, Inc.
|
13.8 million |
- |
-1.72
|
- |
- |
-
|
EYEN Eyenovia, Inc.
|
6.4 million |
0.00% |
-0.05
|
- |
- |
-
|
EYPT EyePoint Pharmaceuticals, Inc.
|
510.6 million |
0.00% |
-3.07
|
- |
- |
-
|
EZZ.AX EZZ Life Science Holdings Limited
|
47.5 million |
0.00% |
7.36
|
2 |
5 |
-
|
FATE Fate Therapeutics, Inc.
|
155.9 million |
0.00% |
-0.91
|
- |
- |
-
|
FBIO Fortress Biotech, Inc.
|
54.4 million |
0.00% |
-0.86
|
- |
- |
-
|
FBIOP Fortress Biotech, Inc.
|
57.1 million |
35.46% |
-9.30
|
12 |
8 |
-
|
FBRX Forte Biosciences, Inc.
|
62.9 million |
0.00% |
-1
|
- |
- |
-
|
FDMT 4D Molecular Therapeutics, Inc.
|
177.4 million |
0.00% |
-1.20
|
- |
- |
-
|
FENC Fennec Pharmaceuticals Inc.
|
217.5 million |
0.00% |
-14.86
|
- |
- |
-
|
FERMENTA.BO Fermenta Biotech Ltd.
|
110.1 million |
- |
12.22
|
1 |
5 |
-
|
FGEN FibroGen, Inc.
|
29.7 million |
0.00% |
-0.24
|
- |
- |
-
|
FHTX Foghorn Therapeutics Inc.
|
243.0 million |
0.00% |
-3.38
|
- |
- |
-
|
FIXX Homology Medicines, Inc.
|
51.9 million |
0.00% |
-0.31
|
- |
- |
-
|
FMTX Forma Therapeutics Holdings, Inc.
|
998.7 million |
- |
-
|
- |
- |
-
|
FNCH Finch Therapeutics Group, Inc.
|
21.8 million |
0.00% |
-1.55
|
- |
- |
-
|
FOLD Amicus Therapeutics, Inc.
|
1.9 billion |
0.00% |
-67.78
|
- |
- |
-
|
FREQ Frequency Therapeutics, Inc.
|
10.9 million |
- |
-42.89
|
- |
- |
-
|
FRLN Freeline Therapeutics Holdings plc
|
28.2 million |
0.00% |
-0.56
|
- |
- |
-
|
FSTX F-star Therapeutics, Inc.
|
156.5 million |
- |
-
|
- |
- |
-
|
FTRE Fortrea Holdings Inc.
|
373.8 million |
0.00% |
-0.49
|
- |
- |
-
|
FULC Fulcrum Therapeutics, Inc.
|
377.3 million |
0.00% |
-699
|
- |
- |
-
|
FUSN Fusion Pharmaceuticals Inc.
|
1.8 billion |
0.00% |
-6.94
|
- |
- |
-
|
FWBI First Wave BioPharma, Inc.
|
5.8 million |
0.00% |
0.00
|
- |
- |
-
|
FWP Forward Pharma A/S
|
20.5 million |
1393.21% |
-7.66
|
- |
- |
-
|
GALT Galectin Therapeutics Inc.
|
81.6 million |
0.00% |
-1.79
|
- |
- |
-
|
GANX Gain Therapeutics, Inc.
|
60.2 million |
0.00% |
-2.42
|
- |
- |
-
|
GBIM GlobeImmune, Inc.
|
2.0 million |
- |
-0.27
|
- |
- |
-
|
GBIO Generation Bio Co.
|
26.0 million |
0.00% |
-0.36
|
- |
- |
-
|
GBT Global Blood Therapeutics, Inc.
|
4.6 billion |
- |
-9.31
|
- |
- |
-
|
GENSF Genus plc
|
1.9 billion |
1.39% |
44.29
|
2 |
13 |
4%
|
GENSY GENUS UNSPON ADR EA REPR 1 ORD
|
1.5 billion |
- |
-
|
- |
1 |
-
|
GERN Geron Corporation
|
980.9 million |
0.00% |
-7.33
|
- |
- |
-
|
GHRS GH Research PLC
|
771.0 million |
0.00% |
-15.73
|
- |
- |
-
|
GLMD Galmed Pharmaceuticals Ltd.
|
3.4 million |
0.00% |
-0.23
|
- |
- |
-
|
GLPG Galapagos NV
|
1.9 billion |
0.00% |
-9.25
|
- |
- |
-
|
GLPG.AS Galapagos NV
|
1.9 billion |
0.00% |
-9.22
|
- |
- |
-
|
GLSI Greenwich LifeSciences, Inc.
|
128.9 million |
0.00% |
-7.59
|
- |
- |
-
|
GLTO Galecto, Inc.
|
4.3 million |
0.00% |
-0.21
|
- |
- |
-
|
GLUE Monte Rosa Therapeutics, Inc.
|
216.9 million |
- |
-1.61
|
- |
- |
-
|
GLYC GlycoMimetics, Inc.
|
13.5 million |
0.00% |
-0.45
|
- |
- |
-
|
GMAB Genmab A/S
|
13.3 billion |
0.00% |
12.56
|
- |
- |
-
|
GMDA Gamida Cell Ltd.
|
4.3 million |
0.00% |
-0.47
|
- |
- |
-
|
GMTX Gemini Therapeutics, Inc.
|
71.1 million |
- |
-
|
- |
- |
-
|
GNCA Genocea Biosciences, Inc.
|
396373 |
- |
-1.64
|
- |
- |
-
|
GNFT Genfit S.A.
|
222.6 million |
0.00% |
149
|
- |
- |
-
|
GNPX Genprex, Inc.
|
8.2 million |
0.00% |
-0.17
|
- |
- |
-
|
GNS.L Genus plc
|
17.6 million |
0.02% |
-328
|
2 |
25 |
2%
|
GNTA Genenta Science S.p.A.
|
79.7 million |
0.00% |
-7.93
|
- |
- |
-
|
GOSS Gossamer Bio, Inc.
|
269.4 million |
0.00% |
-5.39
|
- |
- |
-
|
GOVX GeoVax Labs, Inc.
|
15.8 million |
0.00% |
-0.37
|
- |
- |
-
|
GOVXW GeoVax Labs, Inc.
|
13.4 million |
0.00% |
-
|
- |
- |
-
|
GRAY Graybug Vision, Inc.
|
121.0 million |
- |
-
|
- |
- |
-
|
GRCL Gracell Biotechnologies Inc.
|
989.9 million |
0.00% |
-10.59
|
- |
- |
-
|
GRI GRI Bio, Inc.
|
3.2 million |
0.00% |
0.03
|
4 |
- |
-
|
GRPH Graphite Bio, Inc.
|
189.8 million |
0.00% |
-1.37
|
- |
1 |
-
|
GRTS Gritstone bio, Inc.
|
3.8 million |
0.00% |
-
|
- |
- |
-
|
GRTX Galera Therapeutics, Inc.
|
1.8 million |
0.00% |
-0.09
|
- |
- |
-
|
GTBP GT Biopharma, Inc.
|
7.0 million |
0.00% |
-0.48
|
- |
- |
-
|
GTHX G1 Therapeutics, Inc.
|
377.2 million |
0.00% |
-
|
- |
- |
-
|
GUBRA.CO Gubra A/S
|
1.2 billion |
0.00% |
-208.60
|
- |
1 |
-
|
HALO Halozyme Therapeutics, Inc.
|
6.6 billion |
0.00% |
14.18
|
- |
- |
-
|
HARP Harpoon Therapeutics, Inc.
|
492.3 million |
0.00% |
-14.67
|
- |
- |
-
|
HCWB HCW Biologics Inc.
|
16.2 million |
0.00% |
-0.27
|
- |
- |
-
|
HEPA Hepion Pharmaceuticals, Inc.
|
443443 |
0.00% |
-0.02
|
- |
- |
-
|
HGEN Humanigen, Inc.
|
23816 |
- |
-5.60
|
- |
- |
-
|
HILS Hillstream BioPharma, Inc.
|
4.9 million |
- |
-
|
- |
- |
-
|
HOOK HOOKIPA Pharma Inc.
|
19.3 million |
0.00% |
-0.27
|
- |
- |
-
|
HOTH Hoth Therapeutics, Inc.
|
12.1 million |
0.00% |
-0.87
|
- |
- |
-
|
HRMY Harmony Biosciences Holdings, Inc.
|
2.0 billion |
0.00% |
13.48
|
- |
- |
-
|
HRTX Heron Therapeutics, Inc.
|
305.1 million |
0.00% |
-40
|
- |
- |
-
|
HSTO Histogen Inc.
|
897069 |
0.00% |
-0.12
|
- |
- |
-
|
HTBX Heat Biologics, Inc.
|
81.8 million |
4.65% |
-3.29
|
- |
- |
-
|
HUMA Humacyte, Inc.
|
404.9 million |
0.00% |
-3.78
|
- |
- |
-
|
HUMAW Humacyte, Inc.
|
446.7 million |
0.00% |
-0.17
|
- |
- |
-
|
HURA TuHURA Biosciences, Inc.
|
123.2 million |
0.00% |
-2.94
|
- |
- |
-
|
HVO.L hVIVO plc
|
985281 |
0.00% |
5.28
|
- |
3 |
-
|
IBIO iBio, Inc.
|
13.9 million |
0.00% |
-21.05
|
- |
- |
-
|
IBRX ImmunityBio, Inc.
|
2.4 billion |
0.00% |
-4.68
|
- |
- |
-
|
IBT.L International Biotechnology Trust plc
|
2.8 million |
0.04% |
12.21
|
2 |
8 |
6%
|
ICCC ImmuCell Corporation
|
62.1 million |
0.00% |
-171.75
|
- |
- |
-
|
ICPT Intercept Pharmaceuticals, Inc.
|
794.7 million |
- |
-5.82
|
- |
- |
-
|
IDRA Idera Pharmaceuticals, Inc.
|
18.7 million |
- |
-0.31
|
- |
- |
-
|
IDYA IDEAYA Biosciences, Inc.
|
1.9 billion |
0.00% |
-5.93
|
- |
- |
-
|
IFRX InflaRx N.V.
|
54.4 million |
0.00% |
-0.98
|
- |
- |
-
|
IGC India Globalization Capital, Inc.
|
24.9 million |
0.00% |
-2.60
|
- |
- |
-
|
IGMS IGM Biosciences, Inc.
|
75.1 million |
0.00% |
-0.38
|
- |
- |
-
|
IKNA Ikena Oncology, Inc.
|
64.7 million |
0.00% |
-1.54
|
- |
- |
-
|
IKT Inhibikase Therapeutics, Inc.
|
147.2 million |
0.00% |
-3.41
|
- |
- |
-
|
IMAB I-Mab
|
147.4 million |
0.00% |
-3.28
|
- |
- |
-
|
IMCR Immunocore Holdings plc
|
1.9 billion |
0.00% |
-90.23
|
- |
- |
-
|
IMGN ImmunoGen, Inc.
|
8.7 billion |
0.00% |
-111.54
|
- |
- |
-
|
IMGO Imago BioSciences, Inc.
|
1.2 billion |
- |
-
|
- |
- |
-
|
IMMP Immutep Limited
|
270.7 million |
0.00% |
-7.75
|
- |
- |
-
|
IMMX Immix Biopharma, Inc.
|
57.4 million |
0.00% |
-2.99
|
- |
- |
-
|
IMNM Immunome, Inc.
|
805.7 million |
0.00% |
-3.08
|
- |
- |
-
|
IMPL Impel Pharmaceuticals Inc.
|
8.8 million |
- |
-
|
- |
- |
-
|
IMRA IMARA Inc.
|
165.8 million |
- |
105.33
|
- |
- |
-
|
IMRN Immuron Limited
|
10.1 million |
0.00% |
-2.12
|
- |
- |
-
|
IMTX Immatics N.V.
|
730.5 million |
0.00% |
-31.63
|
- |
- |
-
|
IMTXW Immatics N.V.
|
484.4 million |
0.00% |
-
|
- |
- |
-
|
IMU.AX Imugene Limited
|
73.0 million |
0.00% |
-0.70
|
- |
- |
-
|
IMUX Immunic, Inc.
|
72.3 million |
0.00% |
-0.79
|
- |
- |
-
|
IMV IMV Inc.
|
9.7 million |
- |
-7.90
|
- |
- |
-
|
IMVT Immunovant, Inc.
|
2.6 billion |
0.00% |
-5.66
|
- |
- |
-
|
INBX Inhibrx Biosciences, Inc.
|
195.9 million |
0.00% |
0.11
|
- |
- |
-
|
INCY Incyte Corporation
|
13.0 billion |
0.00% |
335.55
|
- |
- |
-
|
INDP Indaptus Therapeutics, Inc.
|
5.4 million |
0.00% |
-0.23
|
- |
- |
-
|
INFI I:SPX Oct 2023 Weekly 3100.000
|
17.9 million |
- |
-4.52
|
- |
- |
-
|
INKT MiNK Therapeutics, Inc.
|
28.3 million |
0.00% |
-2.89
|
- |
- |
-
|
INM InMed Pharmaceuticals Inc.
|
3.6 million |
0.00% |
-0.26
|
- |
- |
-
|
INMB INmune Bio, Inc.
|
179.0 million |
0.00% |
-3.99
|
- |
- |
-
|
INO Inovio Pharmaceuticals, Inc.
|
79.6 million |
0.00% |
-0.69
|
- |
- |
-
|
INSM Insmed Incorporated
|
13.2 billion |
0.00% |
-12.21
|
- |
- |
-
|
INVA Innoviva, Inc.
|
1.3 billion |
0.00% |
-21.67
|
3 |
- |
-
|
INZY Inozyme Pharma, Inc.
|
257.0 million |
0.00% |
-2.37
|
- |
- |
-
|
IOBT IO Biotech, Inc.
|
101.5 million |
0.00% |
-1.04
|
- |
- |
-
|
IONS Ionis Pharmaceuticals, Inc.
|
5.6 billion |
0.00% |
-11.74
|
- |
- |
-
|
IOVA Iovance Biotherapeutics, Inc.
|
607.8 million |
0.00% |
-1.49
|
- |
- |
-
|
IPA ImmunoPrecise Antibodies Ltd.
|
26.3 million |
0.00% |
-0.47
|
- |
- |
-
|
IP.BK Inter Pharma Public Company Limited
|
56.3 million |
0.00% |
37.75
|
1 |
2 |
-
|
IPHA Innate Pharma S.A.
|
197.2 million |
0.00% |
-3.10
|
- |
- |
-
|
IPSC Century Therapeutics, Inc.
|
48.9 million |
0.00% |
-2.10
|
- |
- |
-
|
ISEE IVERIC bio, Inc.
|
5.5 billion |
- |
-4.87
|
- |
- |
-
|
ITECH.ST I-Tech AB
|
127.0 million |
0.02% |
26.58
|
- |
2 |
-
|
ITOS iTeos Therapeutics, Inc.
|
390.4 million |
0.00% |
-3.34
|
- |
- |
-
|
ITRM Iterum Therapeutics plc
|
38.4 million |
0.00% |
-1.02
|
- |
- |
-
|
IVA Inventiva S.A.
|
470.1 million |
0.00% |
-0.97
|
- |
- |
-
|
IXC.AX INVEX THER FPO [IXC]
|
3.2 million |
0.00% |
-3.25
|
- |
- |
-
|
JAGX Jaguar Health, Inc.
|
5.1 million |
0.00% |
-0.07
|
- |
- |
-
|
JANX Janux Therapeutics, Inc.
|
1.5 billion |
0.00% |
-18.39
|
- |
- |
-
|
JAZZ Jazz Pharmaceuticals plc
|
6.7 billion |
0.00% |
14.87
|
- |
- |
-
|
JNCE Jounce Therapeutics, Inc.
|
101.6 million |
- |
-2.45
|
- |
- |
-
|
JUNS Jupiter Neurosciences, Inc.
|
27.1 million |
- |
-7.45
|
- |
- |
-
|
KALA Kala Pharmaceuticals, Inc.
|
26.4 million |
0.00% |
-0.56
|
- |
- |
-
|
KALV KalVista Pharmaceuticals, Inc.
|
673.1 million |
0.00% |
-3.59
|
- |
- |
-
|
KDMN Kadmon Holdings, Inc.
|
1.6 billion |
- |
-13.43
|
- |
- |
-
|
KDNY Chinook Therapeutics, Inc.
|
1.5 billion |
- |
-2.01
|
- |
- |
-
|
KLDO Kaleido Biosciences, Inc.
|
4262 |
- |
-
|
- |
- |
-
|
KMPH KemPharm, Inc.
|
200.5 million |
- |
17.60
|
- |
- |
-
|
KNTE Kinnate Biopharma Inc.
|
125.0 million |
0.00% |
-0.84
|
- |
- |
-
|
KOD Kodiak Sciences Inc.
|
209.5 million |
0.00% |
-1.09
|
- |
- |
-
|
KPRX Kiora Pharmaceuticals, Inc.
|
11.9 million |
0.00% |
-0.92
|
- |
- |
-
|
KPTI Karyopharm Therapeutics Inc.
|
36.7 million |
0.00% |
-0.36
|
- |
- |
-
|
KRBP Kiromic BioPharma, Inc.
|
318418 |
0.00% |
-0.04
|
- |
- |
-
|
KRON Kronos Bio, Inc.
|
41.5 million |
0.00% |
-0.64
|
- |
- |
-
|
KROS Keros Therapeutics, Inc.
|
607.4 million |
0.00% |
-87.97
|
- |
- |
-
|
KRTX Karuna Therapeutics, Inc.
|
12.6 billion |
0.00% |
-29.07
|
- |
- |
-
|
KRYS Krystal Biotech, Inc.
|
3.6 billion |
0.00% |
30.06
|
- |
- |
-
|
KTRA Kintara Therapeutics, Inc.
|
10.5 million |
0.00% |
-0.01
|
- |
- |
-
|
KTTA Pasithea Therapeutics Corp.
|
6.8 million |
0.00% |
-0.09
|
- |
- |
-
|
KTTAW Pasithea Therapeutics Corp. Warrant
|
25329 |
0.00% |
-
|
- |
- |
-
|
KURA Kura Oncology, Inc.
|
589.6 million |
0.00% |
-
|
- |
- |
-
|
KYMR Kymera Therapeutics, Inc.
|
2.8 billion |
0.00% |
-14.01
|
- |
- |
-
|
KZIA Kazia Therapeutics Limited
|
13214 |
0.00% |
-0.15
|
- |
- |
-
|
KZR Kezar Life Sciences, Inc.
|
32.1 million |
0.00% |
-0.41
|
- |
- |
-
|
LABP Landos Biopharma, Inc.
|
69.4 million |
0.00% |
-1.37
|
- |
- |
-
|
LBPH Longboard Pharmaceuticals, Inc.
|
2.3 billion |
0.00% |
-8.09
|
- |
- |
-
|
LBPS 4D pharma plc
|
37.2 million |
- |
-
|
- |
- |
-
|
LCTX Lineage Cell Therapeutics, Inc.
|
154.8 million |
0.00% |
-9.69
|
- |
- |
-
|
LEGN Legend Biotech Corporation
|
2.8 billion |
0.00% |
-25.73
|
- |
- |
-
|
LENZ LENZ Therapeutics, Inc.
|
821.6 million |
0.00% |
44.23
|
- |
1 |
-
|
LEXX Lexaria Bioscience Corp.
|
18.7 million |
0.00% |
-1.58
|
- |
- |
-
|
LGND Ligand Pharmaceuticals Incorporated
|
2.0 billion |
0.00% |
-13.94
|
- |
- |
-
|
LIAN LianBio
|
34.5 million |
0.00% |
-4.99
|
- |
1 |
-
|
LIFE aTyr Pharma, Inc.
|
131.1 million |
0.00% |
-1.77
|
- |
- |
-
|
LIMNW Liminatus Pharma, Inc. Warrants
|
- |
- |
-
|
- |
- |
-
|
LIXT Lixte Biotechnology Holdings, Inc.
|
3.7 million |
0.00% |
-0.96
|
- |
- |
-
|
LIXTW Lixte Biotechnology Holdings, I
|
71534 |
0.00% |
-
|
- |
- |
-
|
LJPC La Jolla Pharmaceutical Company
|
171.2 million |
0.00% |
38.78
|
- |
- |
-
|
LMNL Liminal BioSciences Inc.
|
21.0 million |
- |
0.71
|
- |
- |
-
|
LOGC LogicBio Therapeutics, Inc.
|
68.2 million |
- |
-3.94
|
- |
- |
-
|
LPCN Lipocine Inc.
|
17.4 million |
0.00% |
-3.22
|
- |
- |
-
|
LPTX Leap Therapeutics, Inc.
|
15.4 million |
0.00% |
-0.22
|
- |
- |
-
|
LQDA Liquidia Corporation
|
1.4 billion |
0.00% |
-9.67
|
- |
- |
-
|
LRMR Larimar Therapeutics, Inc.
|
156.9 million |
0.00% |
-1.62
|
- |
- |
-
|
LTRN Lantern Pharma Inc.
|
36.0 million |
0.00% |
-1.82
|
- |
- |
-
|
LUMO Lumos Pharma, Inc.
|
37.5 million |
0.00% |
-
|
- |
- |
-
|
LVTX LAVA Therapeutics N.V.
|
33.9 million |
0.00% |
-1.22
|
- |
- |
-
|
LXRX Lexicon Pharmaceuticals, Inc.
|
229.5 million |
0.00% |
-1.26
|
- |
- |
-
|
LYEL Lyell Immunopharma, Inc.
|
125.7 million |
0.00% |
-0.32
|
- |
- |
-
|
LYRA Lyra Therapeutics, Inc.
|
26.8 million |
0.00% |
-0.33
|
- |
- |
-
|
MACK Merrimack Pharmaceuticals, Inc.
|
218.4 million |
0.00% |
-138
|
- |
- |
-
|
MAGLE.ST Magle Chemoswed Holding AB (publ)
|
60.2 million |
0.01% |
47.12
|
- |
1 |
-
|
MAIA MAIA Biotechnology, Inc.
|
53.0 million |
0.00% |
-2.33
|
- |
- |
-
|
MAZE Maze Therapeutics, Inc.
|
598.3 million |
0.00% |
195.14
|
- |
- |
-
|
MBIO Mustang Bio, Inc.
|
5.7 million |
0.00% |
-0.09
|
- |
- |
-
|
MBRX Moleculin Biotech, Inc.
|
12.9 million |
0.00% |
-0.18
|
- |
- |
-
|
MBX MBX Biosciences, Inc. Common Stock
|
456.6 million |
0.00% |
-6.21
|
- |
- |
-
|
MCRB Seres Therapeutics, Inc.
|
64.5 million |
0.00% |
-0.93
|
- |
- |
-
|
MDGL Madrigal Pharmaceuticals, Inc.
|
6.1 billion |
0.00% |
-15.43
|
- |
- |
-
|
MDNA Medicenna Therapeutics Corp.
|
11.2 million |
- |
-18.44
|
- |
- |
-
|
MDWD MediWound Ltd.
|
240.4 million |
0.00% |
-10.85
|
- |
- |
-
|
MDXG MiMedx Group, Inc.
|
950.5 million |
0.00% |
23.83
|
- |
- |
-
|
MEIP MEI Pharma, Inc.
|
14.3 million |
0.00% |
-0.45
|
- |
- |
-
|
MENS Jyong Biotech Ltd. Ordinary Shares
|
768.6 million |
- |
-
|
- |
- |
-
|
MESO Mesoblast Limited
|
1.3 billion |
0.00% |
-12.41
|
- |
- |
-
|
MGNX MacroGenics, Inc.
|
95.3 million |
0.00% |
-1.72
|
- |
- |
-
|
MGTA Magenta Therapeutics, Inc. Common Stock
|
44.2 million |
- |
-3.45
|
- |
- |
-
|
MGTX MeiraGTx Holdings plc
|
438.8 million |
0.00% |
-2.36
|
- |
- |
-
|
MIRM Mirum Pharmaceuticals, Inc.
|
2.2 billion |
0.00% |
-28.13
|
- |
- |
-
|
MIRO Miromatrix Medical Inc.
|
93.0 million |
- |
-
|
- |
- |
-
|
MIST Milestone Pharmaceuticals Inc.
|
88.2 million |
0.00% |
-2.14
|
- |
- |
-
|
MITO Stealth BioTherapeutics Corp
|
18.4 million |
- |
-2.07
|
- |
- |
-
|
MLND Millendo Therapeutics, Inc.
|
20.2 million |
- |
-0.64
|
- |
- |
-
|
MNKD MannKind Corporation
|
1.3 billion |
0.00% |
44.25
|
- |
- |
-
|
MNMD Mind Medicine (MindMed) Inc.
|
564.0 million |
0.00% |
-9.95
|
- |
- |
-
|
MNOV MediciNova, Inc.
|
69.4 million |
0.00% |
-6.15
|
- |
- |
-
|
MNPR Monopar Therapeutics Inc.
|
196.4 million |
0.00% |
-8.07
|
- |
- |
-
|
MOLN Molecular Partners AG
|
136.2 million |
0.00% |
-1.78
|
- |
- |
-
|
MOR MorphoSys AG
|
2.9 billion |
0.00% |
-
|
- |
- |
-
|
MORF Morphic Holding, Inc.
|
2.9 billion |
0.00% |
-10.56
|
- |
- |
-
|
MREO Mereo BioPharma Group plc
|
421.3 million |
0.00% |
-7.57
|
- |
- |
-
|
MRKR Marker Therapeutics, Inc.
|
17.1 million |
0.00% |
-1.27
|
- |
- |
-
|
MRNA Moderna, Inc.
|
10.8 billion |
0.00% |
-3.19
|
- |
- |
-
|
MRNS Marinus Pharmaceuticals, Inc.
|
30.4 million |
0.00% |
-
|
- |
- |
-
|
MRSN Mersana Therapeutics, Inc.
|
43.5 million |
0.00% |
-0.59
|
- |
- |
-
|
MRTX Mirati Therapeutics, Inc.
|
4.2 billion |
- |
-4.71
|
- |
- |
-
|
MRUS Merus N.V.
|
4.3 billion |
0.00% |
-14.97
|
- |
- |
-
|
MRVI Maravai LifeSciences Holdings, Inc.
|
306.7 million |
0.00% |
-1.82
|
- |
- |
-
|
MTCR Metacrine, Inc.
|
25.5 million |
- |
-
|
- |
1 |
-
|
MTEM Molecular Templates, Inc.
|
658 |
0.00% |
-
|
- |
- |
-
|
MTNB Matinas BioPharma Holdings, Inc.
|
4.1 million |
0.00% |
-0.20
|
- |
- |
-
|
MTP Midatech Pharma PLC
|
2.0 million |
0.00% |
-0.34
|
- |
- |
-
|
MTSR Metsera, Inc.
|
3.1 billion |
0.00% |
-
|
- |
- |
-
|
MYMD MyMD Pharmaceuticals, Inc.
|
4.5 million |
0.00% |
-0.82
|
- |
- |
-
|
MYMX Mymetics Corporation
|
334134 |
0.34% |
-0.02
|
- |
- |
-
|
MYOV Myovant Sciences Ltd.
|
2.6 billion |
- |
-7.04
|
- |
- |
-
|
NAUT Nautilus Biotechnology, Inc.
|
96.9 million |
0.00% |
-1.42
|
- |
- |
-
|
NAVB Navidea Biopharmaceuticals, Inc
|
3.5 million |
0.00% |
-0.17
|
- |
- |
-
|
NBRV Nabriva Therapeutics plc
|
6.0 million |
- |
-0.62
|
- |
- |
-
|
NBSE NeuBase Therapeutics, Inc.
|
1.4 million |
0.00% |
-0.04
|
- |
- |
-
|
NBTX Nanobiotix S.A.
|
210.7 million |
0.00% |
-2.76
|
- |
- |
-
|
NBY NovaBay Pharmaceuticals, Inc.
|
3.3 million |
0.00% |
0.02
|
- |
- |
-
|
NCNA NuCana plc
|
8605 |
0.00% |
-0.05
|
- |
- |
-
|
NERV Minerva Neurosciences, Inc.
|
12.9 million |
0.00% |
2.26
|
- |
- |
-
|
NEXI NexImmune, Inc.
|
139 |
0.00% |
-0.01
|
- |
- |
-
|
NGEN.V NervGen Pharma Corp.
|
175.6 million |
0.00% |
-8.66
|
- |
- |
-
|
NGM NGM Biopharmaceuticals, Inc.
|
128.5 million |
0.00% |
-0.83
|
- |
- |
-
|
NK NantKwest, Inc.
|
3.6 billion |
- |
-10.73
|
- |
- |
-
|
NKTR Nektar Therapeutics
|
139.5 million |
0.00% |
-1.19
|
- |
- |
-
|
NKTX Nkarta, Inc.
|
125.6 million |
0.00% |
-1.22
|
- |
- |
-
|
NLTX Neoleukin Therapeutics, Inc.
|
31.5 million |
- |
-19.78
|
- |
- |
-
|
NMTR 9 Meters Biopharma, Inc.
|
11.1 million |
- |
-0.88
|
- |
- |
-
|
NNVC NanoViricides, Inc.
|
25.2 million |
0.00% |
-2.28
|
- |
- |
-
|
NOVC.DE Novo Nordisk A/S
|
405.5 billion |
1.06% |
22.93
|
1 |
22 |
12%
|
NOVN Novan, Inc.
|
33.9 million |
- |
-2.25
|
- |
- |
-
|
NOVNQ NVN Liquidation, Inc.
|
2802 |
- |
-
|
- |
- |
-
|
NRBO NeuroBo Pharmaceuticals, Inc.
|
21.6 million |
0.00% |
13.28
|
- |
- |
-
|
NRIX Nurix Therapeutics, Inc.
|
920.9 million |
0.00% |
-4.33
|
- |
- |
-
|
NRSN NeuroSense Therapeutics Ltd.
|
40.3 million |
0.00% |
-3.11
|
- |
- |
-
|
NRSNW NeuroSense Therapeutics Ltd.
|
10.5 million |
0.00% |
-0.47
|
- |
- |
-
|
NRXP NRx Pharmaceuticals, Inc.
|
51.0 million |
0.00% |
-1.51
|
- |
- |
-
|
NRXPW NRx Pharmaceuticals, Inc.
|
1.5 million |
0.00% |
-0.01
|
- |
- |
-
|
NTEC Intec Pharma Ltd
|
46.4 million |
- |
-0.47
|
- |
- |
-
|
NTII Neurobiological Technologies, Inc.
|
10862 |
1.06% |
-
|
1 |
- |
-
|
NTLA Intellia Therapeutics, Inc.
|
792.2 million |
0.00% |
-1.46
|
- |
- |
-
|
NTRB Nutriband Inc.
|
91.0 million |
0.00% |
-
|
- |
- |
-
|
NTRBW Nutriband Inc.
|
29.9 million |
0.00% |
-5.31
|
- |
- |
-
|
NVAX Novavax, Inc.
|
1.2 billion |
0.00% |
2.60
|
- |
- |
-
|
NVIV InVivo Therapeutics Holdings Corp.
|
995917 |
0.00% |
-0.16
|
- |
- |
-
|
NWBO Northwest Biotherapeutics, Inc.
|
381.3 million |
0.00% |
-4.41
|
- |
- |
-
|
NXTC NextCure, Inc.
|
13.3 million |
0.00% |
-0.27
|
- |
- |
-
|
NYKD.OL Nykode Therapeutics AS
|
56.3 million |
0.00% |
-1.67
|
- |
1 |
-
|
NYMX Nymox Pharmaceutical Corporation
|
43.0 million |
- |
-10.83
|
- |
- |
-
|
OBSV ObsEva SA
|
11.0 million |
- |
-1.14
|
- |
- |
-
|
OCEA Ocean Biomedical, Inc.
|
1.6 million |
0.00% |
-0.01
|
- |
- |
-
|
OCGN Ocugen, Inc.
|
248.7 million |
0.00% |
-4.26
|
- |
- |
-
|
OCS Oculis Holding AG
|
931.7 million |
0.00% |
-6.74
|
- |
- |
-
|
OCUL Ocular Therapeutix, Inc.
|
1.3 billion |
0.00% |
-7.50
|
- |
- |
-
|
OCUP Ocuphire Pharma, Inc.
|
31.7 million |
0.00% |
-
|
- |
- |
-
|
ODT Odonate Therapeutics, Inc.
|
51.0 million |
- |
-3.67
|
- |
- |
-
|
OGEN Oragenics, Inc.
|
2.5 million |
0.00% |
-0.14
|
- |
- |
-
|
OKYO OKYO Pharma Limited
|
63.7 million |
0.00% |
-4.95
|
- |
- |
-
|
OLMA Olema Pharmaceuticals, Inc.
|
288.7 million |
0.00% |
-2.11
|
- |
- |
-
|
OMER Omeros Corporation
|
184.0 million |
0.00% |
-1.03
|
- |
- |
-
|
OMGA Omega Therapeutics, Inc.
|
10.4 million |
0.00% |
-0.14
|
- |
- |
-
|
ONCR Oncorus, Inc.
|
547992 |
- |
-
|
- |
- |
-
|
ONCS OncoSec Medical Incorporated
|
3.8 million |
- |
-1.88
|
- |
- |
-
|
ONCT Oncternal Therapeutics, Inc.
|
1.6 million |
0.00% |
-
|
- |
- |
-
|
ONCY Oncolytics Biotech Inc.
|
30.8 million |
0.00% |
-1.20
|
- |
- |
-
|
ONT.L Oxford Nanopore Technologies plc
|
15.5 million |
0.00% |
-7.43
|
- |
- |
-
|
ONTX Onconova Therapeutics, Inc.
|
17.6 million |
0.00% |
-0.68
|
- |
- |
-
|
ONVO Organovo Holdings, Inc.
|
3.7 million |
0.00% |
-0.22
|
- |
- |
-
|
OPNT Opiant Pharmaceuticals, Inc.
|
108.8 million |
- |
34.80
|
- |
- |
-
|
OPORF HVIVO PLC
|
251.6 million |
0.01% |
-
|
- |
- |
-
|
OPT Opthea Limited
|
65.6 million |
0.00% |
-1.52
|
- |
- |
-
|
ORGS Orgenesis Inc.
|
10.1 million |
0.00% |
-0.08
|
- |
- |
-
|
ORIC ORIC Pharmaceuticals, Inc.
|
602.1 million |
0.00% |
-4.51
|
- |
- |
-
|
ORMP Oramed Pharmaceuticals Inc.
|
96.4 million |
0.00% |
-3.32
|
- |
- |
-
|
ORPH Orphazyme A/S
|
86.0 million |
- |
-3.59
|
- |
- |
-
|
ORTX Orchard Therapeutics plc
|
753.2 million |
- |
-4.05
|
- |
- |
-
|
OSMT Osmotica Pharmaceuticals plc
|
65.9 million |
- |
-6.37
|
- |
- |
-
|
OTIC Otonomy, Inc.
|
582482 |
- |
-3.12
|
- |
- |
-
|
OTLK Outlook Therapeutics, Inc.
|
81.9 million |
0.00% |
0.47
|
- |
- |
-
|
OVID Ovid Therapeutics Inc.
|
21.2 million |
0.00% |
-0.88
|
- |
- |
-
|
OYST Oyster Point Pharma, Inc.
|
298.5 million |
- |
-8.09
|
- |
- |
-
|
PALI Palisade Bio, Inc.
|
3.6 million |
0.00% |
-0.13
|
- |
- |
-
|
PASG Passage Bio, Inc.
|
31.0 million |
0.00% |
-0.49
|
- |
- |
-
|
PBLA Panbela Therapeutics, Inc.
|
1.6 million |
0.00% |
-0.01
|
- |
- |
-
|
PBYI Puma Biotechnology, Inc.
|
164.6 million |
0.00% |
4.25
|
- |
- |
-
|
PCSA Processa Pharmaceuticals, Inc.
|
3.4 million |
0.00% |
-0.09
|
- |
- |
-
|
PCVX Vaxcyte, Inc.
|
4.5 billion |
0.00% |
-8.82
|
- |
- |
-
|
PDSB PDS Biotechnology Corporation
|
64.5 million |
0.00% |
-1.50
|
- |
- |
-
|
PGEN Precigen, Inc.
|
391.1 million |
0.00% |
-2.41
|
- |
- |
-
|
PHAR Pharming Group N.V.
|
801.0 million |
0.00% |
-56.07
|
1 |
- |
-
|
PHARM.AS Pharming Group N.V.
|
815.1 million |
0.00% |
-51.75
|
- |
- |
-
|
PHAS PhaseBio Pharmaceuticals, Inc.
|
3.4 million |
- |
-1.33
|
- |
- |
-
|
PHAT Phathom Pharmaceuticals, Inc.
|
328.1 million |
0.00% |
-0.91
|
- |
- |
-
|
PHGE BiomX Inc.
|
13.4 million |
0.00% |
0.02
|
- |
- |
-
|
PHGUF Pharming Group N.V.
|
769.8 million |
- |
-38.33
|
- |
- |
-
|
PHIO Phio Pharmaceuticals Corp.
|
10.1 million |
0.00% |
-0.23
|
- |
- |
-
|
PHIOW Phio Pharmaceuticals Corp.
|
421414 |
- |
-
|
- |
- |
-
|
PHM.MC Pharma Mar, S.A.
|
1.9 billion |
0.89% |
80.71
|
1 |
6 |
-
|
PHMMF PHARMA MAR SA
|
628.5 million |
0.02% |
-
|
- |
- |
-
|
PHR.WA Pharmena S.A.
|
10.3 million |
0.00% |
113.67
|
1 |
1 |
-
|
PHVS Pharvaris N.V.
|
941.6 million |
0.00% |
-5.42
|
- |
- |
-
|
PIRS Pieris Pharmaceuticals, Inc.
|
21.9 million |
0.00% |
-
|
- |
- |
-
|
PLRX Pliant Therapeutics, Inc.
|
97.3 million |
0.00% |
-0.44
|
- |
- |
-
|
PLX Protalix BioTherapeutics, Inc.
|
127.8 million |
0.00% |
32.10
|
- |
- |
-
|
PMCB PharmaCyte Biotech, Inc.
|
7.6 million |
0.00% |
0.82
|
- |
- |
-
|
PMVP PMV Pharmaceuticals, Inc.
|
47.8 million |
0.00% |
-0.78
|
- |
- |
-
|
PNT POINT Biopharma Global Inc.
|
1.5 billion |
- |
12.51
|
- |
- |
-
|
PPBT Purple Biotech Ltd.
|
37244 |
0.00% |
0.01
|
- |
- |
-
|
PRAX Praxis Precision Medicines, Inc.
|
839.2 million |
0.00% |
-3.86
|
- |
- |
-
|
PRDS Pardes Biosciences, Inc.
|
116.3 million |
- |
-
|
- |
- |
-
|
PRLD Prelude Therapeutics Incorporated
|
52.8 million |
0.00% |
-0.56
|
- |
- |
-
|
PRME Prime Medicine, Inc.
|
173.3 million |
0.00% |
-0.82
|
- |
- |
-
|
PROG Progenity, Inc.
|
340.6 million |
- |
-0.48
|
- |
- |
-
|
PRQR ProQR Therapeutics N.V.
|
187.3 million |
0.00% |
-4.81
|
- |
- |
-
|
PRTA Prothena Corporation plc
|
250.8 million |
0.00% |
-2.27
|
- |
- |
-
|
PRTC PureTech Health plc
|
440.0 million |
0.00% |
8.72
|
- |
- |
-
|
PRTG Portage Biotech Inc.
|
9.7 million |
0.00% |
-0.11
|
- |
- |
-
|
PRTK Paratek Pharmaceuticals, Inc.
|
106.0 million |
0.00% |
-4.84
|
- |
- |
-
|
PRVB Provention Bio, Inc.
|
2.3 billion |
- |
-9.92
|
- |
- |
-
|
PSTI Pluristem Therapeutics Inc.
|
32.1 million |
- |
-6.23
|
- |
- |
-
|
PSTV Plus Therapeutics, Inc.
|
6.4 million |
0.00% |
-
|
- |
- |
-
|
PSTX Poseida Therapeutics, Inc.
|
927.9 million |
0.00% |
-
|
- |
- |
-
|
PTCT PTC Therapeutics, Inc.
|
4.0 billion |
0.00% |
7.79
|
- |
- |
-
|
PTE PolarityTE, Inc.
|
3.3 million |
- |
-0.56
|
- |
- |
-
|
PTGX Protagonist Therapeutics, Inc.
|
3.1 billion |
0.00% |
64.29
|
- |
- |
-
|
PTIX Protagenic Therapeutics, Inc.
|
3.2 million |
0.00% |
-0.28
|
- |
- |
-
|
PTIXW Protagenic Therapeutics, Inc. Warrant
|
3.7 million |
0.00% |
-
|
- |
- |
-
|
PTN Palatin Technologies, Inc.
|
6.1 million |
0.00% |
-0.14
|
- |
- |
-
|
PULM Pulmatrix, Inc.
|
31.8 million |
0.00% |
-2.60
|
- |
- |
-
|
PYPD PolyPid Ltd.
|
31.3 million |
0.00% |
-0.73
|
- |
- |
-
|
PYXS Pyxis Oncology, Inc.
|
81.8 million |
0.00% |
-0.82
|
- |
- |
-
|
QLGN Qualigen Therapeutics, Inc.
|
2.9 million |
0.00% |
0.00
|
- |
- |
-
|
QNRX Quoin Pharmaceuticals, Ltd.
|
5.3 million |
0.00% |
-0.26
|
- |
- |
-
|
QURE uniQure N.V.
|
819.0 million |
0.00% |
-3.42
|
- |
- |
-
|
RAIN Rain Oncology Inc.
|
43.7 million |
- |
-
|
- |
- |
-
|
RAPT RAPT Therapeutics, Inc.
|
134.9 million |
0.00% |
-0.41
|
- |
- |
-
|
RARE Ultragenyx Pharmaceutical Inc.
|
3.5 billion |
0.00% |
-6.28
|
- |
- |
-
|
RCKT Rocket Pharmaceuticals, Inc.
|
314.6 million |
0.00% |
-1.11
|
- |
- |
-
|
RCOR Renovacor, Inc.
|
51.2 million |
- |
-
|
- |
- |
-
|
RCUS Arcus Biosciences, Inc.
|
1.0 billion |
0.00% |
-2.26
|
- |
- |
-
|
REGN Regeneron Pharmaceuticals, Inc.
|
51.5 billion |
0.58% |
12.32
|
4 |
1 |
-
|
REPL Replimune Group, Inc.
|
747.0 million |
0.00% |
-3.16
|
- |
- |
-
|
RETA Reata Pharmaceuticals, Inc.
|
3.9 billion |
- |
-13.24
|
- |
- |
-
|
REVB Revelation Biosciences, Inc.
|
852381 |
0.00% |
-0.01
|
- |
- |
-
|
REVBU Revelation Biosciences, Inc.
|
- |
- |
-
|
- |
- |
-
|
REVBW Revelation Biosciences, Inc.
|
15132 |
0.00% |
-
|
- |
- |
-
|
RGLS Regulus Therapeutics Inc.
|
553.2 million |
0.00% |
-11.75
|
- |
- |
-
|
RGNX REGENXBIO Inc.
|
505.6 million |
0.00% |
-3.26
|
- |
- |
-
|
RIGL Rigel Pharmaceuticals, Inc.
|
361.8 million |
0.00% |
9.69
|
- |
- |
-
|
RLAY Relay Therapeutics, Inc.
|
576.1 million |
0.00% |
-
|
- |
- |
-
|
RLMD Relmada Therapeutics, Inc.
|
23.1 million |
0.00% |
-0.28
|
- |
- |
-
|
RNA Avidity Biosciences, Inc.
|
4.1 billion |
0.00% |
-11.41
|
- |
- |
-
|
RNXT RenovoRx, Inc.
|
49.7 million |
0.00% |
-3.32
|
- |
- |
-
|
ROIV Roivant Sciences Ltd.
|
7.6 billion |
0.00% |
-
|
- |
- |
-
|
ROIVW Roivant Sciences Ltd. Warrant
|
- |
- |
-
|
- |
- |
-
|
ROVI.MC Laboratorios Farmaceuticos Rovi, S.A.
|
3.2 billion |
2.07% |
19.74
|
1 |
18 |
30%
|
RPHM Reneo Pharmaceuticals, Inc.
|
43.8 million |
0.00% |
-0.74
|
- |
- |
-
|
RPRX Royalty Pharma plc
Challengers
|
18.7 billion |
2.68% |
13.59
|
4 |
6 |
9%
|
RPTX Repare Therapeutics Inc.
|
62.2 million |
0.00% |
-0.48
|
- |
- |
-
|
RUBY Rubius Therapeutics, Inc.
|
1.7 million |
- |
-2.31
|
- |
- |
-
|
RVMD Revolution Medicines, Inc.
|
7.6 billion |
0.00% |
-10.12
|
- |
- |
-
|
RVNC Revance Therapeutics, Inc.
|
381.0 million |
0.00% |
-
|
- |
- |
-
|
RVPH Reviva Pharmaceuticals Holdings, Inc.
|
38.1 million |
0.00% |
-1.05
|
- |
- |
-
|
RVPHW Reviva Pharmaceuticals Holdings, Inc.
|
34.4 million |
0.00% |
-
|
- |
- |
-
|
RXDX Prometheus Biosciences, Inc.
|
9.3 billion |
- |
-9.98
|
- |
- |
-
|
RXRX Recursion Pharmaceuticals, Inc.
|
2.0 billion |
0.00% |
-2.73
|
- |
- |
-
|
RYTM Rhythm Pharmaceuticals, Inc.
|
4.2 billion |
0.00% |
-23.45
|
- |
- |
-
|
RZLT Rezolute, Inc.
|
373.7 million |
0.00% |
-3.77
|
- |
- |
-
|
SABS SAB Biotherapeutics, Inc.
|
17.3 million |
0.00% |
-0.49
|
- |
- |
-
|
SABSW SAB Biotherapeutics, Inc.
|
332643 |
0.00% |
0.12
|
- |
- |
-
|
SAGE Sage Therapeutics, Inc.
|
408.9 million |
0.00% |
-1.13
|
- |
- |
-
|
SANA Sana Biotechnology, Inc.
|
527.8 million |
0.00% |
-2.66
|
- |
- |
-
|
SAVA Cassava Sciences, Inc.
|
103.9 million |
0.00% |
-1.35
|
- |
- |
-
|
SBBP Strongbridge Biopharma plc
|
135.5 million |
- |
-3.29
|
- |
- |
-
|
SBPH Spring Bank Pharmaceuticals, In
|
5.2 million |
- |
-0.81
|
- |
- |
-
|
SBTX Silverback Therapeutics, Inc.
|
206.2 million |
- |
-
|
- |
- |
-
|
SCPH scPharmaceuticals Inc.
|
217.5 million |
0.00% |
-2.16
|
- |
- |
-
|
SCPS Scopus BioPharma Inc.
|
294590 |
- |
-0.02
|
- |
- |
-
|
SEEL Seelos Therapeutics, Inc.
|
429940 |
0.00% |
0.00
|
- |
- |
-
|
SEER Seer, Inc.
|
115.3 million |
0.00% |
-
|
- |
- |
-
|
SELB Selecta Biosciences, Inc.
|
153.4 million |
- |
10.41
|
- |
- |
-
|
SEPN Septerna, Inc.
|
444.2 million |
0.00% |
-5.60
|
- |
- |
-
|
SESN Sesen Bio, Inc.
|
119.3 million |
- |
1.91
|
1 |
1 |
-
|
SGEN Seagen Inc.
|
41.2 billion |
6.15% |
-54.52
|
- |
- |
-
|
SGMO Sangamo Therapeutics, Inc.
|
122.8 million |
0.00% |
-1.39
|
- |
- |
-
|
SGTX Sigilon Therapeutics, Inc.
|
18.2 million |
- |
-
|
- |
- |
-
|
SION Sionna Therapeutics, Inc.
|
638.9 million |
0.00% |
-9.65
|
- |
- |
-
|
SIOX Sio Gene Therapies Inc.
|
28.8 million |
- |
-1
|
- |
1 |
-
|
SLDB Solid Biosciences Inc.
|
271.3 million |
0.00% |
-1.16
|
- |
- |
-
|
SLGL Sol-Gel Technologies Ltd.
|
20.2 million |
0.00% |
-1.54
|
- |
- |
-
|
SLN Silence Therapeutics plc
|
255.5 million |
0.00% |
-3.54
|
- |
- |
-
|
SLNO Soleno Therapeutics, Inc.
|
3.9 billion |
0.00% |
-16.33
|
- |
- |
-
|
SLRN Acelyrin, Inc.
|
229.2 million |
0.00% |
-0.84
|
- |
- |
-
|
SLRX Salarius Pharmaceuticals, Inc.
|
1.7 million |
0.00% |
-0.22
|
- |
- |
-
|
SLS SELLAS Life Sciences Group, Inc.
|
159.6 million |
0.00% |
-4.44
|
- |
- |
-
|
SMMT Summit Therapeutics Inc.
|
14.4 billion |
0.00% |
-57.53
|
- |
- |
-
|
SMSLIFE.BO SMS Lifesciences India Limited
|
46.2 million |
0.00% |
17.26
|
- |
4 |
-
|
SMSLIFE.NS SMS Lifesciences India Limited
|
46.2 million |
0.00% |
17.24
|
- |
4 |
-
|
SNDX Syndax Pharmaceuticals, Inc.
|
944.8 million |
0.00% |
-2.85
|
- |
- |
-
|
SNGX Soligenix, Inc.
|
6.4 million |
0.00% |
-0.62
|
- |
- |
-
|
SNPX Synaptogenix, Inc.
|
3.6 million |
0.00% |
-0.25
|
- |
- |
-
|
SNSE Sensei Biotherapeutics, Inc.
|
8.9 million |
0.00% |
-0.31
|
- |
- |
-
|
SONN Sonnet BioTherapeutics Holdings, Inc.
|
3.7 million |
0.00% |
-0.10
|
- |
- |
-
|
SPHS Sophiris Bio, Inc.
|
34 |
- |
0.00
|
- |
- |
-
|
SPPI Spectrum Pharmaceuticals, Inc.
|
266.9 million |
0.00% |
-2.93
|
- |
- |
-
|
SPRB Spruce Biosciences, Inc.
|
2.8 million |
0.00% |
-0.05
|
- |
- |
-
|
SPRC SciSparc Ltd.
|
3.4 million |
0.00% |
-0.28
|
- |
- |
-
|
SPRO Spero Therapeutics, Inc.
|
153.2 million |
0.00% |
-2.14
|
4 |
- |
-
|
SQZ SQZ Biotechnologies Company
|
19.0 million |
- |
-
|
- |
- |
-
|
SRNE Sorrento Therapeutics, Inc.
|
168.4 million |
- |
-4.43
|
- |
- |
-
|
SRPT Sarepta Therapeutics, Inc.
|
3.8 billion |
0.00% |
-14.72
|
- |
- |
-
|
SRRA Sierra Oncology, Inc.
|
827.9 million |
- |
-1.06
|
- |
- |
-
|
SRRK Scholar Rock Holding Corporation
|
2.9 billion |
0.00% |
-12.13
|
- |
- |
-
|
SRZN Surrozen, Inc.
|
71.2 million |
0.00% |
-0.33
|
- |
- |
-
|
SRZNW Surrozen, Inc.
|
331.7 million |
- |
-
|
- |
- |
-
|
STAB Statera Biopharma, Inc.
|
42850 |
0.00% |
-
|
- |
- |
-
|
STOK Stoke Therapeutics, Inc.
|
541.1 million |
0.00% |
12.09
|
- |
- |
-
|
STRO Sutro Biopharma, Inc.
|
76.9 million |
0.00% |
-0.31
|
- |
- |
-
|
STSA Satsuma Pharmaceuticals, Inc.
|
34.8 million |
0.72% |
-1.58
|
3 |
- |
-
|
STTK Shattuck Labs, Inc.
|
55.6 million |
0.00% |
-0.84
|
- |
- |
-
|
SUPRIYA.BO Supriya Lifescience Limited
|
667.6 million |
0.00% |
30.54
|
- |
3 |
-
|
SUPRIYA.NS Supriya Lifescience Limited
|
654.4 million |
0.00% |
29.91
|
- |
3 |
-
|
SURF Surface Oncology, Inc.
|
37.6 million |
- |
0.98
|
- |
- |
-
|
SVA Sinovac Biotech Ltd.
|
642.4 million |
2.82% |
6.66
|
- |
- |
-
|
SVRA Savara Inc.
|
414.8 million |
0.00% |
-4.90
|
- |
- |
-
|
SWTX SpringWorks Therapeutics, Inc.
|
3.5 billion |
0.00% |
-13.69
|
- |
- |
-
|
SYBX Synlogic, Inc.
|
13.9 million |
0.00% |
5.42
|
- |
- |
-
|
SYN Synthetic Biologics, Inc.
|
134.7 million |
- |
-0.48
|
- |
- |
-
|
SYNGENE.BO Syngene International Limited
|
3.0 billion |
0.20% |
51.87
|
- |
4 |
-
|
SYNGENE.NS Syngene International Limited
|
3.0 billion |
0.20% |
52.43
|
- |
4 |
-
|
SYRS Syros Pharmaceuticals, Inc.
|
673496 |
0.00% |
-0.01
|
- |
- |
-
|
TALS Talaris Therapeutics, Inc.
|
125.7 million |
- |
-
|
- |
- |
-
|
TARA Protara Therapeutics, Inc.
|
125.5 million |
0.00% |
-2.18
|
- |
- |
-
|
TARS Tarsus Pharmaceuticals, Inc.
|
1.8 billion |
0.00% |
-15.80
|
- |
- |
-
|
TBPH Theravance Biopharma, Inc.
|
566.5 million |
0.00% |
-9.60
|
- |
- |
-
|
TCDA Tricida, Inc.
|
2.4 million |
- |
-1.20
|
- |
- |
-
|
TCON TRACON Pharmaceuticals, Inc.
|
109725 |
0.00% |
0.01
|
- |
- |
-
|
TCRR TCR2 Therapeutics Inc.
|
77.7 million |
- |
-11.16
|
- |
- |
-
|
TCRT Alaunos Therapeutics, Inc.
|
4.6 million |
0.00% |
-1.10
|
- |
- |
-
|
TCRX TScan Therapeutics, Inc.
|
100.7 million |
0.00% |
-1.65
|
4 |
- |
-
|
TECH Bio-Techne Corporation
|
7.8 billion |
0.59% |
60.06
|
4 |
18 |
13%
|
TENX Tenax Therapeutics, Inc.
|
24.4 million |
0.00% |
3.48
|
- |
- |
-
|
TERN Terns Pharmaceuticals, Inc.
|
286.5 million |
0.00% |
-3.04
|
- |
- |
-
|
TFFP TFF Pharmaceuticals, Inc.
|
722882 |
0.00% |
-
|
- |
- |
-
|
TGTX TG Therapeutics, Inc.
|
5.8 billion |
0.00% |
145.64
|
- |
- |
-
|
THRD Third Harmonic Bio, Inc.
|
236.2 million |
0.00% |
-4.22
|
- |
- |
-
|
THRX Theseus Pharmaceuticals, Inc.
|
181.3 million |
0.00% |
-3.03
|
3 |
- |
-
|
THTX Theratechnologies Inc.
|
121.6 million |
0.00% |
-37.79
|
- |
- |
-
|
TIL Instil Bio, Inc.
|
225.7 million |
0.00% |
-2.87
|
- |
- |
-
|
TITANBIO.BO Titan Biotech Limited
|
41.5 million |
0.00% |
15.90
|
1 |
5 |
10%
|
TLC Taiwan Liposome Company, Ltd.
|
294.5 million |
- |
-5.13
|
- |
- |
-
|
TLOG TetraLogic Pharmaceuticals Corporation
|
458720 |
4.85% |
-0.02
|
- |
- |
-
|
TLSA Tiziana Life Sciences Ltd
|
159.4 million |
0.00% |
-13
|
- |
- |
-
|
TMBR Timber Pharmaceuticals, Inc.
|
1.3 million |
- |
-0.05
|
- |
- |
-
|
TNGX Tango Therapeutics, Inc.
|
354.4 million |
0.00% |
-2.72
|
- |
- |
-
|
TNXP Tonix Pharmaceuticals Holding Corp.
|
285.3 million |
0.00% |
0.11
|
- |
- |
-
|
TPST Tempest Therapeutics, Inc.
|
25.4 million |
0.00% |
-0.38
|
- |
- |
-
|
TPTX Turning Point Therapeutics, Inc.
|
3.8 billion |
- |
-31.45
|
- |
- |
-
|
TRDA Entrada Therapeutics, Inc.
|
288.1 million |
0.00% |
13.09
|
- |
- |
-
|
TRIL Trillium Therapeutics Inc.
|
1.9 billion |
5.56% |
-10.91
|
- |
- |
-
|
TRML Tourmaline Bio, Inc.
|
473.7 million |
- |
-5.71
|
- |
- |
-
|
TRVI Trevi Therapeutics, Inc.
|
605.4 million |
0.00% |
-13.22
|
- |
- |
-
|
TRVN Trevena, Inc.
|
993356 |
0.00% |
-0.02
|
- |
- |
-
|
TSHA Taysha Gene Therapies, Inc.
|
608.6 million |
0.00% |
-8.34
|
- |
- |
-
|
TSVT 2seventy bio, Inc.
|
266.1 million |
0.00% |
-
|
- |
- |
-
|
TTNP Titan Pharmaceuticals, Inc.
|
4.4 million |
0.00% |
-1.04
|
- |
- |
-
|
TUB.BR Financière de Tubize SA
|
6.5 billion |
0.63% |
61.87
|
1 |
26 |
30%
|
TVTX Travere Therapeutics, Inc.
|
1.4 billion |
0.00% |
-5.47
|
- |
- |
-
|
TYME Tyme Technologies, Inc.
|
53.5 million |
- |
-4.02
|
- |
- |
-
|
TYRA Tyra Biosciences, Inc.
|
512.3 million |
0.00% |
-5.92
|
- |
- |
-
|
UBX Unity Biotechnology, Inc.
|
12.3 million |
0.00% |
-0.44
|
- |
- |
-
|
UCB.BR UCB SA
|
35.8 billion |
0.73% |
30.29
|
1 |
26 |
-15%
|
UCBJF UCB S.A.
|
23.2 billion |
0.01% |
64.21
|
- |
- |
-
|
UCBJY UCB SA
|
35.6 billion |
1.02% |
29.72
|
1 |
16 |
-
|
UNCY Unicycive Therapeutics, Inc.
|
96.3 million |
0.00% |
-1.42
|
- |
- |
-
|
UPB Upstream Bio, Inc.
|
583.1 million |
0.00% |
-6.49
|
- |
- |
-
|
URGN UroGen Pharma Ltd.
|
226.8 million |
0.00% |
-1.63
|
- |
- |
-
|
UTHR United Therapeutics Corporation
|
14.6 billion |
0.00% |
12.92
|
- |
- |
-
|
VACC Barinthus Biotherapeutics plc
|
192.7 million |
- |
15.64
|
- |
- |
-
|
VALN Valneva SE
|
545.1 million |
0.00% |
-5.09
|
- |
- |
-
|
VAXX Vaxxinity, Inc.
|
12678 |
0.00% |
-0.10
|
- |
- |
-
|
VBIV VBI Vaccines, Inc.
|
1.9 million |
0.00% |
-
|
1 |
- |
-
|
VBLT Vascular Biogenics Ltd.
|
15.0 million |
8.81% |
-2.03
|
- |
- |
-
|
VCEL Vericel Corporation
|
2.1 billion |
0.00% |
831.40
|
- |
- |
-
|
VCNX Vaccinex, Inc.
|
1.9 million |
0.00% |
-0.08
|
- |
- |
-
|
VECT VectivBio Holding AG
|
799.9 million |
- |
-
|
- |
- |
-
|
VERA Vera Therapeutics, Inc.
|
2.0 billion |
0.00% |
-10.66
|
- |
- |
-
|
VERU Veru Inc.
|
90.4 million |
0.00% |
-2.80
|
4 |
- |
-
|
VERV Verve Therapeutics, Inc.
|
427.4 million |
0.00% |
-2.27
|
- |
- |
-
|
VIGL Vigil Neuroscience, Inc.
|
368.7 million |
0.00% |
-3.83
|
- |
- |
-
|
VINC Vincerx Pharma, Inc.
|
287885 |
0.00% |
-0.01
|
- |
- |
-
|
VIR Vir Biotechnology, Inc.
|
729.8 million |
0.00% |
-1.25
|
- |
- |
-
|
VIRI Virios Therapeutics, Inc.
|
4.7 million |
0.00% |
-2.54
|
- |
- |
-
|
VIRX Viracta Therapeutics, Inc.
|
775012 |
0.00% |
-0.02
|
- |
- |
-
|
VKTX Viking Therapeutics, Inc.
|
3.0 billion |
0.00% |
-22.94
|
- |
- |
-
|
VLA.PA Valneva SE
|
556.3 million |
0.00% |
-5.05
|
- |
- |
-
|
VNDA Vanda Pharmaceuticals Inc.
|
258.4 million |
0.00% |
-5.77
|
- |
- |
-
|
VOR Vor Biopharma Inc.
|
28.7 million |
0.00% |
-0.15
|
- |
- |
-
|
VRCA Verrica Pharmaceuticals Inc.
|
50.0 million |
0.00% |
-0.47
|
- |
- |
-
|
VRNA Verona Pharma plc
|
7.3 billion |
0.00% |
-42.81
|
- |
- |
-
|
VRPX Virpax Pharmaceuticals, Inc.
|
310874 |
0.00% |
-0.01
|
- |
- |
-
|
VRTX Vertex Pharmaceuticals Incorporated
|
114.7 billion |
0.00% |
-116.57
|
- |
- |
-
|
VSTM Verastem, Inc.
|
324.2 million |
0.00% |
-1.76
|
- |
- |
-
|
VTGN VistaGen Therapeutics, Inc.
|
63.8 million |
0.00% |
-
|
- |
- |
-
|
VTVT vTv Therapeutics Inc.
|
41.9 million |
0.00% |
-5.71
|
- |
- |
-
|
VTYX Ventyx Biosciences, Inc.
|
141.6 million |
0.00% |
-1.14
|
- |
- |
-
|
VXRT Vaxart, Inc.
|
95.1 million |
0.00% |
-1.60
|
- |
- |
-
|
VYGR Voyager Therapeutics, Inc.
|
184.5 million |
0.00% |
-2.28
|
- |
- |
-
|
VYNE VYNE Therapeutics Inc.
|
16.6 million |
0.00% |
-1.02
|
- |
- |
-
|
VYNT Vyant Bio, Inc.
|
1.2 million |
- |
0.65
|
- |
- |
-
|
WINT Windtree Therapeutics, Inc.
|
2.4 million |
0.00% |
-
|
- |
- |
-
|
WVE Wave Life Sciences Ltd.
|
1.0 billion |
0.00% |
-8.91
|
- |
- |
-
|
WXIBF WuXi Biologics (Cayman) Inc.
|
25.6 billion |
- |
46.31
|
- |
- |
-
|
WXXWY WuXi Biologics (Cayman) Inc.
|
13.1 billion |
0.00% |
29.23
|
- |
- |
-
|
XBIO Xenetic Biosciences, Inc.
|
4.8 million |
0.00% |
-1.30
|
- |
- |
-
|
XBIT XBiotech Inc.
|
89.6 million |
0.00% |
-2.28
|
- |
- |
-
|
XCUR Exicure, Inc.
|
66.1 million |
0.00% |
-2.20
|
- |
- |
-
|
XENE Xenon Pharmaceuticals Inc.
|
2.4 billion |
0.00% |
-
|
- |
- |
-
|
XERS Xeris Biopharma Holdings, Inc.
|
744.7 million |
0.00% |
-16.03
|
- |
- |
-
|
XFOR X4 Pharmaceuticals, Inc.
|
22.9 million |
0.00% |
1.88
|
- |
- |
-
|
XLO Xilio Therapeutics, Inc.
|
34.3 million |
0.00% |
-
|
- |
- |
-
|
XLRN Acceleron Pharma Inc.
|
10.9 billion |
- |
-41.22
|
- |
- |
-
|
XNCR Xencor, Inc.
|
610.6 million |
0.00% |
-2.82
|
- |
- |
-
|
XOMA XOMA Corporation
|
289.8 million |
0.00% |
-33.17
|
- |
- |
-
|
XOMAO XOMA Corporation
|
302.8 million |
8.36% |
25.27
|
4 |
5 |
-
|
XOMAP XOMA Corporation
|
308.4 million |
8.41% |
25.74
|
4 |
5 |
30%
|
XRTX XORTX Therapeutics Inc.
|
3.5 million |
0.00% |
-9.34
|
- |
- |
-
|
XTLB XTL Biopharmaceuticals Ltd.
|
10.3 million |
0.00% |
-3.88
|
- |
- |
-
|
YECO EV Biologics, Inc.
|
6.1 million |
- |
-0.49
|
- |
- |
-
|
YMAB Y-mAbs Therapeutics, Inc.
|
221.2 million |
0.00% |
-7.63
|
- |
- |
-
|
YMTX Yumanity Therapeutics, Inc.
|
22.0 million |
- |
-
|
1 |
1 |
-
|
ZEAL Zealand Pharma A/S
|
814.1 million |
- |
-13.97
|
- |
- |
-
|
ZGNX Zogenix, Inc.
|
892.0 million |
- |
-3.56
|
- |
- |
-
|
ZIOP ZIOPHARM Oncology, Inc.
|
220.5 million |
- |
-7.57
|
- |
- |
-
|
ZIVO ZIVO Bioscience, Inc.
|
66.7 million |
0.00% |
-3.59
|
- |
- |
-
|
ZIVOW Zivo Bioscience, Inc.
|
35.3 million |
0.00% |
-
|
- |
- |
-
|
ZLAB Zai Lab Limited
|
3.4 billion |
0.00% |
-12.45
|
- |
- |
-
|
ZNTL Zentalis Pharmaceuticals, Inc.
|
97.9 million |
0.00% |
-0.43
|
- |
- |
-
|
ZOTA.NS Zota Health Care Limited
|
311.9 million |
0.00% |
-51.26
|
- |
8 |
4%
|
ZSAN Zosano Pharma Corporation
|
66.0 million |
- |
-0.33
|
- |
- |
-
|
ZYME Zymeworks Inc.
|
811.1 million |
0.00% |
-7.76
|
- |
- |
-
|